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Summary
Over the last decades, proton magnetic resonance spectroscopy (1H-MRS) has been
used in several studies in order to detect human brain metabolites. The signal to
noise ratio (SNR) and spectral resolution are important quality measurements of
MRS. Therefore, many MR spectroscopy techniques have been proposed to achieve
improvements. One of the major localization techniques is single volume spectroscopy
(SVS) which employs pulse sequences based on spin echoes (PRESS) or stimulated
echoes (STEAM). It was shown that low magnetic field strengths leads to peak overlaps
of human brain metabolites such as Glutamate with Glutamine and NAA with NAAG.
Moreover, at high field strength the limited available RF transmitter power causes
difficulty in achieving a true 90o excitation or 180o refocusing flip angle in standard
sequences such as STEAM or PRESS.
In this work, a 24 channel volume coil has been used to acquire spectra from deep
brain areas. To reduce the required RF peak power and to decrease the pulse duration
to be available for human studies, variable-rate selective excitation (VERSE) has been
applied to the standard spectroscopy RF sequence (STEAM).
The aim of this thesis was to establish a proton magnetic resonance spectroscopy
method to obtain accurate quantification of in vivo metabolites such as Gln, GABA
and NAAG, which will benefit from the increased sensitivity at ultra high magnetic
field strength (7 Tesla). This 1H-MRS method should be used to investigate human
brain metabolites in deep human brain regions.
For this project an adapted MRS sequence for 7T (STEAM with VERSE) was
developed. Twenty metabolite solutions had been prepared and then measured at
7T. These build an experimental basis set for metabolite quantification. Moreover,
a simulated basis set was calculated using NMR-SIM software and compared to the
Xexperimental results.
The results show for the first time the detection and quantification of fifteen human
brain metabolites in deep brain regions such as the pregenual anterior cingulate cortex
(pgACC), anterior middle cingulate cortex (AMCC), posterior cingulate cortex (PCC)
and Brodmann area 23 C.
Finally, we have succeeded to measure Gln, GABA and NAAG levels by using
1H-MRS at 7T, which could not be separated at lower field strengths using standard
MRS sequences (STEAM or PRESS). It is tempting to conclude that separating Gln
and Glu may be useful for patients who suffer from major depressive disorder (MDD).
Zusammenfassung
Magnetresonanzspektroskopie an Wasserstoffkernen (1H-MRS) ist in den letzten
Jahrzehnten von vielen Arbeitsgruppen zur Erforschung verschiedener Erkrankungen
eingesetzt worden. Als wichtige Qualita¨tskriterien einer 1H-MRS sind die Messung des
Signal-zu-Rausch-Verha¨ltnisses (SNR) und der spektralen Auflo¨sung dokumentiert.
Dafu¨r wird u¨blicherweise Single-Voxel-Spektroskopie (SVS) mit Pulssequenzen, die
auf Spin Echos (PRESS) oder auf stimulierten Echos (STEAM) basieren, benutzt. Es
wurde bereits gezeigt, dass es bei niedrigeren Feldsta¨rken als 7T zu U¨berlappungen
(im gemessenen Spektrum) der im menschlichen Hirn vorhandenen Metaboliten, wie
z.b. Glu mit Gln oder NAA mit NAAG, kommen kann. Andererseits fu¨hrt die
bei 7T vorhandene B1 Inhomogenita¨t und die (durch SAR-Grenzen) eingeschra¨nkte
verfu¨gbare Senderleistung zu groen Schwierigkeiten bezu¨glich des Erreichens eines
genauen 90o Hochfrequenz-Sendepulses mittels der bisher als Standard verwendeten
PRESS und STEAM Sequenzen. Verschiedene fru¨here Studien konnten zeigen,
dass die Erho¨hung der magnetischen Feldsta¨rke vorteilhaft fu¨r die Separation der
Metaboliten im gemessenen Spektrum der 1H-MRS ist. Ebenso konnte ein ho¨heres
SNR und gleichzeitig eine ho¨here Sensitivita¨t im Vergleich zu niedrigeren Feldsta¨rken
nachgewiesen werden.
Bei den vorangehenden Hochfeld-MRS-Studien wurden Oberfla¨chenspulen
verwendet; dadurch konnten tiefere Hirnregionen nicht untersucht werden.
In dieser Arbeit wurde fu¨r die Erfassung von Spektren tieferer Hirnareale
mittels 1H-MRS eine 24-Kanal-Spule verwendet. Weiterhin wurde zur
Reduzierung der beno¨tigten HF-Sendeleistung und damit zur Verku¨rzung der
Pulsdauer ”Variable-Rate-Selective-Excitation” (VERSE) in der Standardsequenz
fu¨r Spektroskopie, STEAM, implementiert. Ein Ziel dieser Arbeit ist die genaue
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Mengenbestimmung von Metaboliten wie Gln, GABA und NAAG in vivo unter
Nutzbarmachung der ho¨heren Sensitivita¨t bei Ultra-Hochfeld-MRS (7 Tesla). Auerdem
erfolgt in dieser Arbeit die Untersuchung einer tieferen Hirnregion (nahe dem
Corpus Callosum) unter Verwendung einer 24-Kanal-Spule. Dafu¨r wurde ebenfalls
die speziell fu¨r Ultra-Hochfeld-MRS modifizierte Sequenz (STEAM mit VERSE)
benutzt. Insgesamt zwanzig Proben von Metaboliten des menschlichen Hirns wurden
vorbereitet und an einem 7 Tesla Magnetresonanztomografen vermessen. Basissa¨tze
von Spektren wurden experimentell erhoben und verarbeitet. Weiterhin wurden
zwanzig Spektren-Datensa¨tze mittels NMR-SIM simuliert.
Die Resultate zeigen erstmalig die Erkennung von 15 verschiedenen
Hirn-Metaboliten in tieferen Hirnregionen (anterior cingulate cortex (pgACC),
anterior middle cingulate cortex (AMCC), posterior cingulate cortex (PCC) and
Brofmann area 23 C). Die Konzentration dieser Metaboliten wurde mittels LCModel
Basissets (experimentell und simuliert, kurze und lange Echozeiten) fu¨r 7T bestimmt.
Schlussendlich konnten die Anteile von Gln, GABA und NAAG mittels 1H-MRS
bei 7T erfolgreich bestimmt werden. Dies war bisher bei niedrigeren Feldsta¨rken
nicht mo¨glich. Die durch die Separation von Gln und Glu bei Ultra-Hochfeld-MRS
entstehenden Mo¨glichkeiten der Untersuchung von Patienten, die an Depressionen
(Major Depressive Disorder, MDD) leiden, erscheinen viel versprechend.
Chapter 1
Introduction
Proton magnetic resonance spectroscopy 1H-MRS is an effective way to study the
human brain metabolites non-invasively and provides markers for specific diseases [1, 2].
Signal to noise ratio, spatial and spectral resolution as well as scan time are some
of the important quality measurements of MRS. Several localization methods have
been proposed. Single volume spectroscopy (SV S) localization techniques use pulse
sequences based on spin echoes (PRESS) [3] or stimulated echoes (STEAM) [4] and
provide the highest spectral quality with limited spatial information. Lower magnetic
field strengths result in peak overlap of the human brain metabolites, such as Glu
with Gln and NAA with NAAG. Besides, standard spectroscopic sequences such as
STEAM or PRESS will suffer if limited transmitter voltage is available. This results
in a reduced excitation flip angle and consequently inefficient excitation in the volume
of interest (VOI). Moreover, previous studies have investigated that an increase in the
magnetic field strength increases the 1H-MR spectral peak separation, signal to noise
ratio (SNR) and thus provides higher sensitivity compared with lower field strengths
[5, 6, 7, 8, 9, 10, 11]. With standard RF amplifiers and volume RF coils at 7T, short
180o refocusing pulses are difficult to achieve in most parts of the brain. Earlier high
field MRS studies, therefore, frequently employed surface coils with locally higher B1
field amplitude [12, 13]. However, not all brain areas can be adequately examined
using surface coils. As the goal of this study was to examine the deeper areas of the
human brain, the STEAM volume selection principle has been applied. The 90o-pulses
require only half the peak power of the 180o-pulses in PRESS. Moreover, STEAM with
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short echo times benefits from reduced signal decay due to J-evolution of the coupled
spin system, thus allowing a more precise quantification of the metabolites, especially
with short T2 relaxation time [14]. Short echo times have been used in several studies
[15, 16, 17, 18] as well as in this work, TE was selected to be 20 ms. Earlier studies that
had employed STEAM with ultra short echo times were again limited by the surface
coils which prevented detection in the deep brain regions. TEs down to 6 ms were
possible and the metabolites were resolved better at 7T than at 3T [14]. A quadrature
(transmit/receive) surface RF coil or a half-volume RF coil have been used for these
studies [19, 20].
In this thesis, a 24-channel volume coil has been used to acquire spectra from deep
brain areas. To reduce the required RF peak power and decrease the pulse duration,
variable-rate selective excitation (VERSE) [21] had been applied into the standard
spectroscopy RF sequence (STEAM) [22]. Therefore, the aim of this thesis was to
establish a proton magnetic resonance spectroscopic method to obtain an accurate
quantification of in vivo metabolites such as Gln, GABA and NAAG, which will benefit
from the increased sensitivity at ultra high magnetic field strength (7 Tesla). After
that, this 1H-MRS method will be used to investigate human brain metabolites in
deep human brain regions, around the corpus callosum using a 24-channel volume coil.
Throughout this project an adapted MRS sequence especially suited for 7T application
(STEAM with VERSE) was used. Twenty human brain metabolite solutions had
been prepared and then measured at 7T. The spectra of the experimental basis set
were acquired and processed. Twenty spectra have been simulated using NMR −
SIM software. Our results show for the first time the detection of 15 human brain
metabolites in the deep parts of the brain (pgACC, AMCC, PCC and Brodmann 23 C
region). At the same time, the concentration of these brain metabolites was calculated
using the LCModel basis sets (experimental and simulated, using short and long echo
times) at 7T. This method proved to be successful to measure Gln, GABA and NAAG
levels by using 1H-MRS at 7T, which could not be earlier separated at lower field
strengths. It, therefore, becomes tempting to conclude that separating Gln and Glu can
be helpful, especially when scanning patients suffering with Major Depressive Disorder
(MDD) [23, 24].
This was achieved by following five stages of investigations; selection and
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optimization of the sequence parameters resulting in high spectral resolution spectra,
measurement of 20 human brain metabolite solutions using short and long echo times,
simulation of the same 20 metabolite spectra using the NMR−SIM program, creation
of experimental and simulated basis sets using 20 in vitro spectra and 20 simulated
spectra respectively, creation of LCModel basis sets which were used in the analysis of
the acquired human spectra.
More than 80 human brain spectra from 30 healthy subjects (age 23-35 years) were
measured in 5 brain regions at 7T. Further, the metabolite concentrations have been
quantified by the LCModel program.
Chapter 2
Magnetic Resonance Spectroscopy
In this chapter, the following sections will be explained in detail: 1H-MR spectroscopy
phenomenon, spin quantum numbers, magnetization vector, Larmor frequency,
relaxation times T1, T2 and T
∗
2 , chemical shift, localized spectroscopy, MRS techniques
and MRS data analysis in frequency domains.
2.1 1H-MR Spectroscopy Phenomenon
Proton magnetic resonance spectroscopy (1H-MRS) is a non-invasive tool used to
investigate human brain metabolites from brain structures [25]. The phenomenon of
1H-MRS can be described as follows: when the proton of hydrogen atom (1H) is
exposed to an external magnetic field B0, certain amount of energy is absorbed. This
absorbed energy is released as electromagnetic waves at a resonant frequency (Larmor
frequency) in the range of radiofrequency waves [26].
2.2 Macroscopic Rotational Angular Momentum
Any rotating particle possesses a rotational angular momentum . The orientation of it
can be described by the right hand rule, where, if the fingers wrap in the direction of
the rotation, the thumb points along the angular momentum orientation [27].
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2.3 Microscopic Rotational Angular Momentum
Atoms have been documented to consist of subatomic particles like electrons, protons
and neutrons which are always rotating [28]. In quantum mechanics, their angular
momenta are quantized. Moreover, a rotating molecule (e.g, H2O) has several stable
rotational states denoted by (J). The total angular momentum (Lt) can be calculated
by the following Equation [27].
Lt =
√
J(J + 1)h¯ (2.1)
where J = 0, 1, 2 . . . and h¯ = 1.054×10−34 J s ( the reduced Planck constant, h/2pi).
Figure 2.1: The rotational energy states of a molecule such as H2O in the absence of
magnetic field and on applying it.
As seen in Fig. 2.1, the molecule can be in a stable energy state i.e., with total
angular momentum Lt = 0 or
√
2h¯, or
√
6h¯, etc. Further information on molecule
rotation is given by the quantum number (MJ) where, MJ = 2J + 1 integer values.
Moreover, MJ sometimes refers to the number of sublevels.
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2.3.1 Spin Angular Momentum
The electron of the hydrogen atom has two motions; a circulating motion around the
nucleus (angular momentum, L) and an intrinsic motion (spin angular momentum, S).
Particles with spin S have (2S + 1) sublevels on applying an external magnetic field
[26].
2.3.2 Nuclear Spin Quantum Number I
Spin is an intrinsic property of the particle itself. It is also a form of angular momentum.
The nuclear spin quantum number (I ) of any given nucleus depends on the proton
number Z and neutron number N . Nuclei whose Z and N are even-even numbers, have
a nuclear spin quantum number I = 0 and they are inactive in NMR spectroscopy. The
elements whose Z and N are even-odd or odd-even numbers, have nuclear spin quantum
numbers I, with the values (I = 1/2, 3/2, ...). Add to this, the nuclei whose Z and N
are odd-odd numbers (I = 1, 2, 3, ...).
The spin of a system, therefore, consists of two particles and is a combination of
their spin i.e., I = (I1 − I2) or (I1 + I2). If I1 = 1/2 and I2 = 1/2, I = 0 (antiparallel
spin orientations, high energy state) and I = 1 (parallel spin orientations, low energy
state) [29].
2.3.3 Nuclear State Splitting
Consider a nucleus of spin I, with (2I + 1) energy states. These states have the same
energy in the absence of an external magnetic field (the degeneracy case). As seen in
Fig. 2.1 the magnetic field breaks the degeneracy to 2I + 1 sublevels. This process is
called nuclear Zeeman splitting [30].
2.3.4 Nuclear Magnetic Momentum µ
The motion of a proton around its rotational axis generates a magnetic moment µ,
which depends upon spin angular momentum S, along the axis of rotation [29]. The
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relation between these quantities is explained by the following Equation.
−→µ = γ−→S (2.2)
2.4 Magnetization Vector
The vector of summation of the magnetic momentums is nonzero when an external
magnetic field is applied. Moreover, the orientation of this vector points parallel to
the field direction, as seen in Fig. 2.2. In other words, the tissue gets polarized
or magnetized in the presence of the external magnetic field with a value of net
magnetization (M0). At equilibrium, the spins are in the stable state . Moreover,
Equation 2.3 indicates that the magnitude of M0 is proportional to the magnetic field
strength B0 [31].
−→
M0 = χv
−→
B0 (2.3)
where M0 is the net magnetization vector of the material (the magnetic dipole moment
per unit volume) and is measured in amperes per meter. B0 is the magnetic field
intensity measured in Tesla while χv is the volume magnetic susceptibility (no unit) and
χv = µr− 1, where, µr = µmµ0 (relative permeability, the ratio between the permeability
of material (µm) to the permeability of free space (µ0 = 4pi10
−7H/m)).
2.5 Larmor Frequency
The nuclei with spin quantum number (I > 0), have their energy states split into
different energy sublevels when they are localized in the external magnetic field B0.
The exact number of protons in each energy state is governed by a distribution known
as the Boltzmann distribution [32], as shown below:
Nupper
Nlower
= exp(−∆E
KT
) (2.4)
where (Nupper) and (Nlower) are the number of protons in the upper and lower energy
states, respectively, and K is Boltzmann’s constant, 1.381 x 10−23 J k−1.
Moreover, when the nuclei are irradiated with radiofrequency (RF ) pulses, energy
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Figure 2.2: The net magnetization M0 of a sample along the magnetic field direction
B0, at equilibrium. The coordinates (x, y and z) are right-handed.
absorption occurs, and the spin in the lower energy state flips to the higher energy
state. The difference in energy between the two energy states can be calculated using
the following equation,
4 E = γ h
2pi
B0 (2.5)
where, (4E), γ , and h represent the differences in energy, gyromagnetic constant, and
Planck’s constant, respectively.
Besides, the introduced frequency (ν) at which the absorption energy occurs can
be calculated using equation 2.6 [30].
ν =
4E
h
(2.6)
where, (4E) is the absorbed RF energy which is equal to the energy difference between
the two energy states. Substituting4E from equation 2.5 in equation 2.6, the resonance
condition is obtained.
ν = γ
B0
2pi
(2.7)
ω = γB0 (2.8)
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where ω = 2piν, and is the Larmor frequency (radians per second, rad s−1). Moreover
ν is the linear frequency in Hz. Equation 2.8 is established as the necessary resonance
condition [33]. Fig. 2.3 shows the circular and precession motions of a proton in
external magnetic field Bo.
Figure 2.3: Applying an external magnetic field B0 leads to the magnetization vector
being tilted away from the z axis. The proton has two motion: one around its own axis
that is denoted by the magnetic moment µ and a pressing motion around the direction
of B0. The magnetic moment sweeps by a certain angle from the B0 direction. The
vector sweeps out a cone of constant angle to the magnetic field direction. This pressing
frequency is known as the Larmor frequency ω0.
2.6 Relaxation Times T1, T2 and T
∗
2
It was stated that, when the nuclei absorb a certain amount of energy (equal to the
energy difference between the two energy states), they are excited to a higher energy
state, which occurs immediately after the excitation 90o pulse of the RF applied pulses.
The return of the nuclei to the lower energy state is associated with loss of energy to the
surroundings, which happens when the RF turns off. Therefore, the net magnetization
returns to equilibrium during the spin-lattice or longitudinal relaxation time (T1). Fig.
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2.4 shows that T1 can be defined as the time for M(t) return to 63 % of its original
value M0. Moreover, at time = 3 T1, the z-component returns to 95% of M0. The
relation between the Mz magnetization component and T1 can be illustrated by the
following equation [34],
Mz(t) = M0[1− exp (− t
T1
)] (2.9)
Figure 2.4: The relaxation times, the spin-lattice or longitudinal relaxation time, T1.
Equation 2.10 indicates the relation between the spin-spin or transverse relaxation
time (T2) and the Mxy magnetization component in the xy plane. During T2 the spins
in the higher and lower energy states exchange without loss to the surrounding nuclei.
The transverse magnetization component Mxy decays at the rate of (1/T2). Within the
relaxation time T2, the net magnetization reached to 37 % of the original value, as seen
in Fig. 2.5.
Mxy(t) = Mxy(max)(exp (− t
T2
)) (2.10)
Relaxation rate =
1
T2
(2.11)
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Figure 2.5: The relaxation times (spin-spin or transverse relaxation time, T2).
1
T ∗2
=
1
T2
+ γ 4 B (2.12)
Equation 2.11 shows the relaxation rate with units of s−1, where in equation 2.12, the
total transverse relaxation time, T ∗2 , depends on the relaxation rate of tissue T2 plus
the magnetic field inhomogeneity of the external magnetic field 4B [35].
2.7 Sequence Times TR, TE and Received Signal
The repetitions time (TR) and echo time (TE) parameters are related to the tissue
relaxation times (T1) and (T2), respectively. However, unlike T1 and T2, which represent
the inherent properties of the tissue, and therefore, are fixed, TR and TE can be
adjusted. Moreover, changing the values of TR and TE affects on T1 and T2 weighting,
depending on the clinical applications.
2.7.1 Repetition Time (TR)
TR defined as the time interval between the two applications such as two 90o pulses.
The magnetization vector points along the Z direction where (Mz = M0). At (t = +0),
immediately after (t = 0) , the magnetization in the X-Y plane has the component
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(Mxy = M0). As t = TR, some magnetization along the Z-direction is recovered and
some or all magnetization is lost in the X-Y plane. The final magnetization at t =
TR is shown by the following [36].
Mz(TR) = M0[1− exp (−TR
T1
)] (2.13)
i.e. the magnetization (Mz) at time (t = TR) is smaller than the original
magnetization (M0) if the second 90
o pulse is applied before recovering total (T1).
2.7.2 Received Signal
Because the series of 90o pulses alone are applied, the signal received (S) will be a series
of FIDs. The signal S is proportional to the term (1− exp (−TR
T1
)) and the spin density
(NH) as illustrated in equation 2.14.
S = NH(1− exp (−TR
T1
)) (2.14)
2.7.3 Echo Time (TE)
The signal cannot be measured immediately after the RF pulse goes off without delay.
This cannot really happen in practice. Instead of making the measurement immediately
after the RF pulse, we need to wait for a short time period and then record the
signal. This time is called the time of echo (TE) and related to T ∗2 by the quantity
(exp (−TE/T ∗2 )) [36]. Equation 2.15 illustrates the received signal depending on TE
and TR.
S = NH [exp (−TE
T ∗2
)][1− exp (−TR
T1
)] (2.15)
2.8 Chemical Shift
The circulation of electrons around the nucleus induces a magnetic field (Bi), which is
opposed to the external magnetic field. In accordance with this induced field, the total
magnetic field strength is reduced. This reduction is called magnetic shielding [29].
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The relation between Bi and B0 can be expressed by the following relation
Bi = σB0 (2.16)
The term σ (refers to the diamagnetic shielding constant) where, its value depends
on the electron density of any atom. The chemical shift is interpreted relative to the
increase or decrease of electron density [37]. Therefore, the effectiveness of the applied
magnetic field on the atomic nucleus (Beff ) is
Beff = B0 − σB0 = B0(1− σ) (2.17)
The chemical shift is defined as the difference between the reference frequency (ωref )
in Hz and the sample frequency (ωsample) in Hz.
4 ω = ωsample − ωref (2.18)
As tetramethylsilane (TMS) is regarded as the reference material, the frequency
difference, chemical shift, (4ω) will increase with the increased Bo. Further, the
chemical shift in Hz must be divided by the frequency of the spectrometer in Hz
and multiplied by 106 to negate the effect of the different magnetic field strengths.
Therefore, the chemical shift is recognized by (δ) and measured in ppm instead of in
Hz [37].
δ =
4ω
ωspectrometer
106 (2.19)
For example, at 7T, the chemical shift between the water and fat signals was
estimated using equation 2.19, where the resonance frequencies for water and fat
are separated by approximately 3.5 ppm, which in turn corresponds to an absolute
frequency difference of 1043 Hz.
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Figure 2.6: The chemical shift in ppm between water and the fat spectra at 7 T.
2.8.1 Chemical Shift Displacement
The frequency of spins with Larmor frequency (ωo) in the presence of a magnetic field
gradient (Gx) in x direction is given by:
ω(x) = ω0 + γ∆xGx
∆ω = ω(x)− ω0 = γ∆xGx
(2.20)
where, ∆ω = ω(x) − ω0 is the difference in the chemical shift between two different
compounds, like water and fat. 4x is the chemical shift displacement in the x-direction
[38].
De Graaf and et al., 2000 [39] illustrated that the voxel size (Vi, i = x, y, z) can be
defined as the ratio between the RF bandwidth and the magnetic gradient strength.
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Vi =
RFbandwidth(Hz)
gradientstrength(Hz/cm)
(2.21)
Thus,
Vi =
∆ν
γGi
(2.22)
As the gradient field strength is defined as the change of the magnetic field relative to
distance, then
Vi =
∆ν
γ ∆B
∆Vi
(2.23)
Or,
Vi =
∆ν
γ∆B
∆Vi (2.24)
Therefore, the two voxels corresponding to their resonances will be shifted by the
amount of
∆Vi =
γ∆B
∆ν
Vi (2.25)
Or,
4 x = 4ω
∆ν
X (2.26)
where, the chemical shift displacements in the y-direction and z-direction are 4y and
4z, respectively.
2.8.2 J-Coupling
Consider a system of two protons HA and HB which resonate as doublets. Fig. 2.7
shows the chemical shifts and coupling constant (in Hz) of the doublet lines. The two
coupled protons HA and HB are separated by three chemical bonds. The coupling
constant between HA and HB is JAB. Moreover, the dotted lines at δA and δB show
the chemical shift of HA and HB, respectively, before they influence each other. The
spin-spin splitting refers to the number of neighboring protons. In this example, there
are two peaks for each proton i.e. each proton has only one neighboring proton [40].
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Figure 2.7: Chemical shift and J-coupling of two coupled protons HA and HB (spin-spin
splitting). The coupling constant 3JAB, (3) indicates the number of chemical bonds,
and (AB) shows the coupled protons.
2.8.3 Multiplicity (m)
Multiplicity refers to the number of spectral peaks and gives the number of neighbor
protons (n) where, m = n + 1 [41]. For example, γ-Aminobutric (GABA) compound
consists of four carbon atoms bonded with hydrogen atoms as shown in Fig. 2.8 (A).
The GABA spectrum (in range 0.4-4.4 ppm) has three groups of peaks; Group (A)
contains five peaks (i.e., n+1=5 or n=4) or four neighbor protons. Group (B) and (C)
have two neighbor protons for each one.
2.9 Localized Spectroscopy and MRS Techniques
The two common methods used in MR spectroscopy studies are single volume
spectroscopy (SVS) and chemical shift imaging (CSI). By utilizing the SVS technique,
when a certain volume of interest (VOI) was excited, the desired spectra were obtained.
Fig. 2.9 (A) shows the examined VOI using SVS technique. As seen in Fig. 2.9 (B),
several spectra were obtained from the field of view (FOV) using the CSI method [42].
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Figure 2.8: 1HMRS spectrum of GABA solution measured at 7T. (A) The chemical
structure of the compound and (B) The spectral peaks in the range 0.4 ppm to 4.4
ppm.
Figure 2.9: The localization techniques for MR spectroscopy applications (A) The SVS
shows the intersection of three slices (VOI) (B) The CSI shows several voxels of FOV.
2.10 DATA Processing in Frequency Domain
The measured free induction decay (FID) signal is in the time domain. This
signal can be converted to the frequency domain using Fourier transformation (FT).
Processing in the frequency domain offers an easy way to reduce the data analysis to
a limited frequency region of the MRS spectra. However, under certain conditions,
frequency-selective quantitative data analysis in the time domain is also feasible
[43, 44, 45].
Magnetic Resonance Spectroscopy 18
The following post processing steps can be applied after acquiring the FID signals.
2.10.1 Eddy Current Correction(ECC)
The eddy current producing the raw data could be problematic to phase shifts. The
effect of these eddy currents on the MRS spectrum can be compensated by subtracting
the phase of the unsuppressed water signal from the suppressed water signal to be
evaluated [46].
2.10.2 Fourier Transformation
Fourier transformation (FT) is a mathematical algorithm used to translate the
measurement signals from the time domain (the measured signal) into the frequency
domain (spectrum).
2.10.3 Baseline Correction
The incomplete suppression of the water signal, spectra may exhibit some degree of
distortion (baseline). This distortion is often strong particularly around the water
signal. The baseline can be corrected using an nth order polynomial fitting to the
spectrum. This polynomial is subtracted from the original spectrum, resulting in a
more horizontal baseline. A flat baseline is essential for the integration of metabolite
signals which is important for metabolite quantification. The baseline can be modified
manually: it can also be done automatically by using the LCModel through spline
functions [47].
2.10.4 Phase Correction
A complex spectrum consists of a real part and an imaginary part. These represent
the frequency-dependent x and y projections of the transverse magnetization of the
spins. Phase correction can be achieved with two processes zero order phase correction
and first order phase correction. The amount of phase correction is related to each
individual peak in the spectrum [46, 48].
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2.10.5 Curve Fitting
Spectra often contain a large number of peaks, making it difficult to assign metabolites
to the individual peaks. For example, several human brain metabolite peaks can be
quantified in the frequency domain in the range from 0.2 ppm to 4.2 ppm, as mentioned
under Results. The linear combination of in vitro spectra of model solutions of human
brain metabolites can be used as the basis set of a commercial program known as
LCModel [47].
The human brain metabolite concentrations can be estimated in the frequency
domain using this model. As the basis set and the in vivo data are generally not
acquired under identical conditions, leading to different scaling, scaling the human brain
spectra by a water scaling factor (fscale) becomes important to determine the absolute
concentrations [49]. With water scaling, the LCModel multiplies the data by fscale
to scale the data consistently with the basis set. Incidentally, fscale is defined as the
ratio of the normalized signal strength in the basis set to the normalized unsuppressed
water signal in in vivo data. Further, the metabolite absolute concentrations can be
calculated using the following equation,
Conmet = Ratioarea × 2
N1Hmet
× ATTH2O
ATTmet
×Wconc (2.27)
where Conmet is the metabolite concentration. Ratioarea is the ratio of the metabolite
resonance area to the unsuppressed water resonance area. N1Hmet demonstrates
the number of the equivalent proton in the metabolite groups. Wconc is the water
concentration in the examined VOI in mM/L. ATTmet and ATTH2O the attenuation
factor of the metabolite and water, respectively.
Chapter 3
Materials and Methods
In this chapter, the preparation and measurement of 20 human brain metabolite
solutions are described. The total number of healthy subjects is identified. Besides, the
methods used in this research are clearly explained. Section 3.1 generally represents
the context of the current chapter.
3.1 Experimental Set Up
All the in vivo and in vitro measurements were performed on a whole body 3T
and 7T systems (Siemens, Erlangen, Germany). The measured data was saved in
a spectroscopy raw data format. Localized proton magnetic resonance spectroscopy
was used as a MRS technique [4]. The stimulated-echo acquisition mode (STEAM)
was adapted and optimized by introducing variable rate selective excitation (VERSE)
pulses to reduce the RF peak voltage at 7T.
Further, STEAM adapted with the VERSE pulses of pulse durations of 2.5 ms,
TR=3000 ms, TE=20 ms, TM=15 ms and voxel size (15 × 15 × 15) mm3, 3600 Hz
spectral band width, and 2048 sample points were optimized at 7T. A 24-channel
volume coil was used for measurement of the human brain spectra, and a circular
polarized coil (CP) was used to acquire the in vitro spectra. Thus, the simulated and
experimental basis sets were achieved.
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3.2 Materials
In this work, 20 model solutions of human brain metabolites were prepared. They
measured at 7T and their spectra were acquired. These in vitro spectra were used
to create the experimental basis set for the LCModel [47]. Concentration, molecular
weight, and the initial mass of these 20 metabolites have been described in Table 3.1.
All the chemicals were bought from Sigma-Aldrich.
Table 3.1: Twenty metabolite solutions and reference substances of LCModel basis set
Metabolite Symbol C (mmol) M.W(g/mol) I.W(g)
L-Alanine Ala 100 89.090 0.356
Acetate Act 200 82.040 0.656
Aspartate Asp 40 133.100 0.213
Citrate Cit 200 294.100 2.353
Creatine Cr 50 149.150 0.373
γ-Aminobutric Acid GABA 200 103.120 0.825
Glucose Glc 200 180.160 1.441
L-Glutamine Gln 100 146.150 0.585
Glutamate Glu 50 187.140 0.468
Glycine Gly 200 75.070 0.601
Glycerophosphocholine GPC 33 440.540 0.581
Gluthatione GSH 70 307.330 0.861
myo-Inositol Ins 200 180.160 1.441
L-Lactate Lac 100 112.060 0.448
N-acetylaspartate NAA 50 175.140 0.438
Phosphocholine PCho 27 329.730 0.356
Phosphocreatine PCr 50 155.100 0.510
phosphorylethanolamine PE 50 141.060 0.282
Succinate Suc 100 270.100 1.080
Taurine Tau 200 125.150 1.001
Reference Markers
Sodium Formate HCOONa 200 68.010 13.602
Trimethylsilyl propionate TMSP 10 172.280 1.723
Dipotassium phosphate K2HPO4 72 174.180 11.287
Monopotassium phosphate KH2PO4 28 136.090 3.429
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3.2.1 Preparation of the Model Solutions
Spherical phantoms made of plastic of 40 mm diameter were used as solution containers.
The standard solvent is consisted of (200 mM/L of Na-formate and 10 mM/L of
TMS), was solved in one liter of distilled water. Some of the model solutions did
not dissolve in the solvent, due to the phosphate content, such as (GPC) and (PCh).
Therefore, 100 mL of the solvent was added to (72 mM/L of K2HPO4 and 28 mM/L
of KH2PO4) to prepare these metabolites. Then 900 mL of the solvent without any
additions was used to prepare all the other metabolites.
The pH values of several metabolites such as NAA, Lac and Glu, were adjusted to
7.2 using careful titration with concentrated NaOH or HCl to avoid their resonance
shift.
3.2.2 Reference Peaks
Na-formate and TMS are the two reference substances which were used in this
work. As Na-formate concentration was the same in all the model solutions, the
Na-formate resonance peak was found to be around 8.44 ppm and it was used to
scale the 20 in vitro spectra consistently with each other. TMS also has singlet at 0
ppm. The Na-formate and TMS singlets are also used by the LCModel for automatic
phasing. Therefore, it is important to use the same reference marker for all the model
metabolites. The chemical structure of the TMS and Na-formate are indicated in
Fig. 3.1.
Figure 3.1: Chemical structures of (A) TMS and (B) Na-formate reference substances
The temperature of the solution is often adequate for acquiring the quality spectra
at 7 T. It is best to adjust the phantom temperature closer to the room temperature.
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In this work, all the metabolite solutions were left in the scanner room for three hours
before beginning the measurements.
3.2.3 Compatibility Requirement
To analyze in vivo or in vitro spectra, a basis set must be obtained and some conditions
need to be matched, such as the static magnetic field strength (B0), localization
sequence, TE, TM (in STEAM only). However, TR, vector size, acquisition time,
and spectral bandwidth do not have to be matched.
3.3 Human Subjects
In this study, all volunteers were healthy subjects between 23 and 35 years. The number
of subjects and their spectra were classified into three groups.
1. Group one was related to the parietal locations. The volunteers were in number
8 while the spectra numbered 32.
2. Group two was related to the pgACC regions. Eleven subjects were measured at
7T while three of them were measured at 3T for comparison. The total number
of subjects was 11 and the acquired spectra were 14.
3. Group three includes 6 volunteers who were measured at 7T. Four positions were
selected (pgACC , AMCC, Brodmann area (23C) and PCC ) have been measured
with short TE=20 ms. Two of them (pgACC and AMCC) were measured with
long TE=74 ms. Therefore, the total number of subjects in this group was 6 and
the total number spectra was 36.
Finally, the number of subjects measured was 30 and the total number of acquired
spectra was 82.
3.4 Methods
Point resolved spectroscopy (PRESS) was used at 3T [3] and stimulated echoes
(STEAM) at 7T [4]. Experimental basis sets of 20 model solutions were measured
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at 7T using (STEAM with VERSE) pulses with different echo times and mixing times.
Twenty human brain metabolite simulated spectra have been done using ”WIN-SIM”
NMR spectroscopy software. Creation of ”BASIS” files was done for the LCModel. In
addition, a segment of the original image to gray matter (GM), white mater (WM) and
cerebrospinal fluid (CSF) images was obtained using ”SPM” software and the partial
volume of GM was calculated using the ”imageJ” software.
3.4.1 Acquiring the Basis Spectra
STEAM with VERSE pulses of (pulse durations 2.5 ms, TR=3000 ms, TE=74/30/20
ms, TM=15 ms and voxel size 15×15×15 mm3, 3600 Hz spectral band width, and 2048
sample points) are maintained the same throughout all measurements. It is essential
that the basis spectra are scaled consistently with each other, Therefore, the in vitro
spectra were acquired under the same conditions viz., the position of the phantom
in the magnet, acquisition time and spectral bandwidth. Additionally, the voxel was
located in the center of the phantom in order to fix the coordinates of the VOI position
in all the phantoms. Moreover, it was found best if all the spectra were acquired with
the same time period.
3.4.2 Introduction to LCMgui and Makebasis.in File
LCMgui is a graphical mode used to analyze the acquired spectroscopy data. When
the LCMgui processing was used, 11 files were produced. One of them was a ”ps”
file which included a spectral fit, concentration values, fit residual and other spectral
information.
3.5 Shimming
The quality of the acquired spectra depends upon the shimming quality achieved for
MRS examinations, where, by changing the shim currents, FWHM and T ∗2 can be
optimized. Moreover, interactive shimming compensates for inhomogeneities of the
magnetic field. This has been confirmed by users. Therefore, the user can adjust the
shimming currents to obtain high quality spectrum with a line width as narrow as
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possible [50, 51, 52, 53]. At 3T and 7T, interactive and automatic 3D shim have been
used.
3.6 Water Suppression
It is important to mention that, in in vivo measurements the water signal has more than
10000 times higher than the metabolite signals, as seen in Fig. 3.2 (A). Therefore, it is
necessary to suppress the water signal in order to obtain sufficient signals of the human
brain metabolites. The effect of the water suppression process has been shown in Fig.
3.2 (B). The method most frequently used in MR spectroscopy is selective excitation
and dephasing of the water signal prior to the actual spectroscopy experiment. As seen
in Fig. 3.3, the chemical shift selective suppression (CHESS) sequence consists of three
90o pulses applied before the PRESS or STEAM pulses [54, 55]. Sometimes it is good
to use the manual water adjustment to optimize the flip angle, where, the flip angles
are set for optimal suppression of the water signal by determining a correction factor
for the transmitter amplitude of these RF pulses [56].
3.7 RF Pulse Sequences
Consider that an RF sequence consists of three 90o pulses as shown in Fig. 3.4. This
pulse sequence generates five echoes and three FIDs [57, 25]. When the first two pulses
are separated by a delay (TE/2) and the last two pulses are separated by a TM , four
spin echoes (SE) are formed. Pulses 1 and 2 form the spin echo (SE12), which occurs
at a time TE after the initial excitation pulse. (SE13) is formed at (TE + 2TM),
(SE23) at (TE/2 + 2TM) and (S123) occurs at position (2TM). (S123) occurs due to
refocusing by pulses 2 and 3 of magnetization excited by pulse 1. Add to these four
(SEs), a stimulated echo (STE) is formed at position (TE + TM) or after a delay
(TE/2) following the last 90o pulse.
Moreover, the positions of the different (SEs) depend on the timing parameters TE
and TM , while the relative amplitudes depend on the flip angles of the RF pulses. In
MR spectroscopy measurements, (STE) is the signal of interest. Therefore, the FID
and other (SEs) signals need to be eliminated in order to obtain only (STE). Those
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Figure 3.2: 1H-MRS spectrum represents (A) Water signal besides the metabolite
signals (unsuppressed water option). (B) The metabolite signals besides the water
(after water suppression was done).
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Figure 3.3: Water suppression (CHESS) pulses.
Figure 3.4: Three FIDs (FID1, FID2, and FID3) achieved for spin
echoesSE12, SE13, SE23, andSE123 respectively. Moreover, one stimulated echo
(STE) can be generated. (A) The echoes appear at distinct temporal positions,
depending on the (TE) and TM periods. (B) The (ADC) of the four echoes have been
shown respect to time scale.
signals can be eliminated by using magnetic field gradients. By placing a magnetic
gradient in the TM period, all SEs are eliminated leaving only the (STE). Add to
Materials and Methods 28
this, the FID component increases due to the last 90o excitation pulse [58].
3.8 PRESS, STEAM, and VERSE
Two techniques are commonly used in human magnetic resonance spectroscopy
to obtain spectra from localized volumes in the brain. These are point resolved
spectroscopy (PRESS) and stimulated echo acquisition mode (STEAM). PRESS gives
a signal twice as large as that obtained with STEAM, but suffers from longer minimum
echo times, while STEAM must be used to detect samples with short TE times. Several
authors have used PRESS and STEAM sequences as excitation and selection methods
[59, 25, 60, 61, 62].
3.8.1 Point Resolved Spectroscopy (PRESS)
As seen in Fig. 3.5, the PRESS sequence consisting of an 90o excitation pulse and two
180o refocusing pulses. When the first 180o pulse is executed at time (TE1/2) after
the 90o pulse, a spin echo is formed at time 8TE1). The second 180
o pulse refocuses
this spin echo during the delay (TE2), such that the final spin echo is formed at time
(TE = TE1 + TE2). The three RF pulses are frequency selection and are executed in
combination with the magnetic field gradients [38].
3.8.2 Stimulated Echo Acquisition Mode (STEAM)
Three slice selective 90o pulses are used in the stimulated echo acquisition method
(STEAM) [4]. The first pulse flips the net magnetization vector M0 into the XY plane.
The second pulse flips part of the spins back into the Z-direction. The remaining
transverse net magnetization decays through TM and does not contribute to the
acquired MRS signal. The third pulse flips the magnetization back into the xy plane.
After TE/2, a stimulated echo is produced as FID. During TM , the longitudinal
magnetization is subjected to T1 relaxation. Fig. 3.6 shows the schematic diagram
of the stimulated echo RF pulses of the STEAM sequence with the magnetic field
gradient pulses (Gx, Gy and Gz) which were used for slice selection [38].
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Figure 3.5: PRESS sequence with three RF pulses applied simultaneously with the
field gradients along the main axes of the magnet.
Figure 3.6: Sequence scheme for the STEAM sequence. The refocusing gradients need
to be positioned before the second RF pulse and after the third RF pulse.
3.8.3 Variable Rate Selective Excitation (VERSE)
The variable rate pulse (V R) is considered a spatially selective RF pulse; it is also a
time varying gradient [63]. Variable rate pulses are also known as variable rate selective
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excitation (VERSE) pulses [21]. One main application of V R pulses is the RF power
reduction which is placed in patients [64]. Moreover, in order to maintain the nominal
flip angle when the RF amplitude is reduced, the V R pulse is stretched. This in turn
reduces the RF bandwidth at any portion of the pulse. Fig. 3.7 (A) shows an example
of an original pulse while Fig. 3.7 (B) shows a modified sinc pulse with an applied
gradient [64].
Figure 3.7: Variable-rate modification to a sinc RF pulse. (A) The original RF
envelope A0 is attenuated wherever the gradient amplitude G0is reduced. (B)
VR-modified sinc pulse of amplitude AV R with a concurrent gradient GV R
3.9 Simulation Database
This section explains the data simulation using the nuclear magnetic resonance
simulation program (NMR − SIM) to simulate metabolite spectra as they are in
a real experiments. However, the calculation is based on an ideal spectrometer (i.e.
ignoring the effects such as magnetic field inhomogeneity). Several parameters can be
modified to study the impact of non-optimum conditions on a spectrum. The FID
is calculated from the solution of the Liouville - Von Neumann equation, which is
called the density operator equation. The spin system of any metabolite and the pulse
sequence are explained in detail in Appendix (C). Moreover, in order to simulate the
FID signal of any metabolite, two parameters should be established
1. RF pulse sequence
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2. Spin system of each metabolite
The simulation of an NMR experiment is based on the density matrix approach.
Relaxation phenomena are implemented using a model based on the Liouville equation.
Cross-correlation and cross relaxation effects are ignored.
Furthermore, the Bloch simulator module is designed to calculate and visualize the
motion of the
−→
M through the NMR experiment. The motion of the magnetization
vector is described by the equation 3.1. Fig. 3.8 shows the amplitude and phase of a
simulated RF-sinc pulse using the applied frequency of 297.14 MHz. Moreover, Fig.
3.9 indicates the Fourier transform of the 90o RF profile using STEAM with VERSE
pulses at 7T. Moreover, the simulated RF bandwidth was simulated and equal to 3600
Hz.
dMz
dt
= −γ(−→B ×−→M) + Mz −
−→
M0
T1
(3.1)
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Figure 3.8: Pulse shape display in NMR-SIM
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Figure 3.9: The excitation profile of the sinc 90o pulse of the STEAM with VERSE
pulses.
3.10 Instruments
3.10.1 Magnet System
The magnet system generates the basic magnetic field B0. The magnet comprises a
superconductive electrical magnet including the cooling system (interface for helium
fill/refill, cold head), monitoring the magnet during the operation [42]. Moreover, the
superconducting magnet produces a strong homogeneous magnetic field with strength
of 7 Tesla. The magnet jacket is filled with liquid helium acting as the coolant. Fig.
3.10 shows the 7T whole body scanner.
3.10.2 Gradient System
The gradient system produces linear dynamic magnetic field gradients in three
directions (X, Y, and Z). The gradient coil and the gradient amplifier are the two
components of this system. The first is comprised to the coil systems to generate the
gradient field. The second is used to generate and regulate the gradient current.
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Figure 3.10: The whole body 7 Tesla system
3.10.3 Shimming Coil
The local variation of the magnetic field is different for each examined subject. The
distribution of the magnetic field can be modified by varying the electric current within
the shim coils, which produce additional magnetic fields of different spatial shapes.
This process, called shimming, is necessary for spectroscopic measurements. The MRI
scanner includes additional built-in coils known as shimming coils [58]. The current
flowing in the shim coil controls the strength of the magnetic shim field.
3.10.4 Single Volume Coil
The transmitter / receiver coil excites the hydrogen atoms in the voxel and is to be
examined as homogeneously as possible. All affected spins should have the same level
of excitation. The receiver coil is used to receive an MR signal with as little noise as
possible. The signal to noise ratio is dependent upon the excited volume in the coil and
on the distance between the receiver coil and the VOI (filling factor) [65]. All the basis
set spectra were acquired at 7T using the High-pass BirdCage coil. The model consists
of a single tuned, highpass birdcage quadrature coil mounted in a shielded cylindrical
plastic house [66].
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3.10.4.1 CP Coil
The Doty quadrature coil (CP) interface is used to interface the Doty LitzCage Model
to the 7T MRI whole body scanner. This device can split the RF transmission signal
from the scanner into two quadrature signals that feed the volume coil. During the
receipt of the acquired signal, the quadrature coil interface amplifies the MRI signal
from both channels before sending them into the scanner.
Doty Litzcage coil includes the Circular-Polarization (CP) of the RF -birdcage coils,
the insulated crossovers of the Doty linear Litz coil, and a novel symmetrising network
to provide extraordinary B1 homogeneity, superior SNR and exceptional simplicity
in tuning to widely varying samples. The tuning of the small volume coil includes
connecting the RF sweeper and adjusting the volume coil as shown in Fig. 3.11 (A).
Preparing the measurement requires a connection between the two terminal connectors
(right and left) of the interface box with the volume coil and a connection between the
interface box with the scanner side as indicated in Fig. 3.11 (B).
Figure 3.11: Volume coil setup (A) Tuning the coil at the 7T frequency circa 300MHz,
(B) Connection of the coil with the scanner.
3.10.5 24 Channels Volume Coil)
All in vivo data was acquired by the 24 channels volume coil (Coil Set, Nova Medical,
Inc.) at 7T MRI devices. This coil was designed for high human brain performance
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imaging/spectroscopy on the 7T whole body instrument.
All the 24-channel particularly are used as receiver coils and only the volume coil is
used as the transmitter coil. The volume transmit coil is based upon 30 cm diameter
multiplied by the 20 cm long volume resonator enclosed within the 38 cm shield and
open at both ends of the coil body.
Chapter 4
Results
The main goal of this work is to establish an 1H MRS method to detect and quantify
a large number of human brain metabolites in the various brain areas, especially
those that are not resolved at fields lower than 7T, such as Gln, GABA and NAAG.
This study includes five stages of investigation, selection and optimization of the RF
sequence parameters that produce good spectral resolution, measurement of 20 human
brain metabolite solutions at short and long echo times, simulation of the same 20
metabolite spectra, creating the LCModel database of the in vitro spectra (measured
and simulated databases), and finally using the created LCModel file to analyze the
acquired human spectra.
4.1 RF -Flip Angle Optimization at 3T and 7T
The radiofrequency field B1 is used to rotate the net magnetization vector M of a
sample by a defined flip angle. The inhomogeneity of B1 causes local variation of
the flip angle in the sample. Therefore, the true flip angle depends on the position
in the sample and may lead to a reduced signal and thus the efficiency. Localized
adjustment of water suppression is routinely performed. However, local adjustment is
time consuming. In this section, the experimental results demonstrate that the correct
transmission voltage for signal generation can be calculated based on the local water
suppression adjustment. Therefore, the current method optimizes the MR-spectroscopy
RF flip angle resulting in the highest signal without additional scan time. To exploit
the local water suppression (WS) adjustment for optimum signal, measurements were
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Figure 4.1: Different positions in a phantom sample (gray scale of the gradient echo
image inverted)
performed on the whole body 3T and 7T systems. Single voxel proton spectra of a
phantom were recorded in various positions in both scanners. A global adjustment was
done for the whole sample to obtain a gradient-echo image using TR = 100 ms, TE =
4ms, 8-channel head coil. Fig. 4.1 shows various positions, one of them at the center of
the sample, where the B1 field typically is the strongest and the other positions were
distributed around the center where B1 is lower.
Within the spectroscopy software supplied by the vendor a correction factor
(Cf), defined as the ratio between the experimental WS voltage adjustment and the
calculated WS voltage was present. A linear relationship exists between the correction
factor and the applied WS voltage. Therefore, when the correction factor equals to
one, the water suppression is correctly calculated and the true flip angle is achieved.
At 3T and 7T, PRESS and STEAM sequences have been applied respectively.
Ing both fields, the following parameters have been used: TR = 10 s, TE = 136 ms
V OI = 20 × 20 × 20 mm3, TM = 20 ms (for STEAM only), flip angle = 90o, eight
channel volume coil, WS-bandwidth = 35 Hz. The excitation voltage was varied from
110 V to 360 V at 3T and from 100 V to 400 V at 7T, for each voltage the maximum
amplitude of water signal was determined.
A relationship between the water signal and the transmission voltage has been
established for each position. Table 4.1 illustrates the data at different positions in the
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Table 4.1: Correction factors and voltages at 3T and 7T scanners
At 3T(PRESS) At 7T(STEAM)
position 1 position2 position1 position2
Cf 0.9454 1.0635 Cf 0.8890 1.1970
90o 296.764 296.764 90o 274.522 274.522
180o 367.733 367.733 90o 274.522 274.522
180o 367.733 367.733 90o 274.522 274.522
ws1 8.736 10.971 ws1 11.328 15.385
ws2 8.168 10.557 ws2 10.591 14.384
ws3 15.748 19.777 ws3 20.421 27.734
sample at 3T and 7T, all data are in volts, except for the correction factor which is
unitless. 90o, 180o, 180o are the three spectroscopy pulses of the RF field and (ws1,
ws2 and ws3) are the three water suppression pulses.
The correction factor Cf varied from one position to another due to B1 field
inhomogeneity. As shown in Table 4.1, at 3T the three RF voltages are different
for the PRESS sequence (90o−180o−180o). But at 7T the three voltages are identical
for STEAM sequence (90o − 90o − 90o).
At 3T, the excitation voltage which is the transmission voltage for the 90o excitation
pulse (Vexc) was varied from 110 V to 360 V and the water signal intensity was recorded.
In order to exactly determine the voltage for true 90o flip angle, the signal model
f(x) = a ∗ sin(b ∗ x) has been used in order to fit the data points. Where f(x) is the
water signal intensity in (a.u.), x is applied voltage in volt and (a, b) are constants.
Fig. 4.2 shows the water signal amplitude as a function of the transmitted excitation
voltages at one position in the sample.
At 7T, a STEAM sequence has been used. Thus, three identical 90o pulses are
employed and the voltage for all three pulses has been modified simultaneously. Fig.
4.3 shows the variation of the transmitted voltages of the STEAM sequence from 100
V to 400 V together with the measured water signal intensity at 7T. Besides, 240
V results in the highest water signal. As all three pulses have been modified in the
STEAM sequence, the function f(x) = a ∗ sin3(b ∗ x) has been used in order to fit
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Figure 4.2: Measured data points of one position acquired at 3T while the red line is
the fit using the equation f(x) = a ∗ sin(b ∗ x).
the data points and to calculate the voltage for the 90o flip angle. Fig. 4.2 and Fig.
4.3 refers to only one position at 3T and 7T, where Vcal is the calculated transmission
voltage corresponding to the 90o flip angle. Fit parameters were calculated in MATLAB
at both fields.
Table 4.2 shows that for each position in the sample, one flip angle corresponds to
the highest signal (the experimental value) Vexc and the calculated voltage Vcal which
predicted from the reference value. The ratio Vcal/Vexc is calculated and compared to
the correction factor. Fig. 4.4 (A and B) illustrates the linear relationship between the
ratio Vcal/Vexc and the correction factor Cf at 3T and 7T, respectively. F (x) = a∗x+b
is a model of fit the data points where F (x) is the ratio Vcal/Vexc, x represents the Cf ,
and a and b are the slope and y-axis intersection, respectively.
Vcal = Vexc ∗ Cf (4.1)
Finally, when the spectroscopy measurement is done at a position far from the
center where B1 is different from the nominal value the true flip angle is not achieved.
This problem is solved by using Equation 4.1. Vexc and Cf are determined from the
standard adjustment and thus the optimal transmission voltages that produce the
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Figure 4.3: The fitting curve using f(x) = a ∗ sin3(b ∗ x) for the experimental data
points of one position examined at 7T
nominal true flip angle in the sample can be calculated. Therefore, based on the
spectroscopy adjustments to determine the water saturation voltage and the correction
factor, a new reference voltage can be calculated by multiplication of the original value
with the WS correction factor. If a second water suppression adjustment is performed,
the new correction factor is approximately one i.e. the correct flip angle has been
achieved. Table 4.3 indicates different values of the correction factor before and after
using equation 4.1.
4.2 Comparison between STEAM and STEAM
with VERSE Pulses
The results of the previous section show that the required transmitted voltage for the
true 90o flip angle changes as the position of the voxel changes in the sample. Also, it
was clear that the standard sequences STEAM and PRESS need high power to achieve
the true excitation flip angle. Therefore, STEAM adapted with variable rate selective
excitation (VERSE) [22] was used in order to reduce the required power. A comparison
between the standard STEAM and the STEAM with VERSE was done to estimate
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Figure 4.4: The relationship between the correction factor and the fraction Vcal/Vexc
at 3T B) The relationship between the correction factor and the fraction Vcal/Vexc at
7T.
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Table 4.2: The excitation voltages and the calculated voltages for different positions
at 3T and 7T.
At 3T
Position 1 Position 2 Position 3 Position 4 Position 5
Cf 0.9454 1.0635 1.1077 0.9846 1.0579
Vexc 296.764 296.764 296.864 297.144 297.44
Vcal 271.487 306.268 319.076 285.255 305.186
Vcal
Vexc
0.9148 1.032 1.0748 0.96 1.026
At 7T
Position 1 Position 2 Position 3 Position 4 Position 5
Cf 0.8890 1.1970 0.9450 1.1567 1.2420
Vexc 274.522 274.522 274.522 262.118 262.118
Vcal 226.339 314.432 248.151 297.4990 311.665
Vcal
Vexc
0.8245 1.1454 0.9039 1.1350 1.1890
the degree of power reduction. Fig. 4.5 shows the relation between the required
transmitted voltage and the water signal intensity. This comparison has been done in
the range from 160 to 550 V. For each voltage, the water signal intensity was recorded.
All data were acquired at 7T with scan parameters TR/TE/TM = 3000/20/15 ms,
which remained the same during all the measurements, except that the VERSE factor
changed from 1 to 1.4 for standard STEAM sequence to STEAM with VERSE pulses,
respectively. The calculated transmit voltage Vcal in equation 4.1 can be used to adjust
the voxel which is located far from the center of the sample. Moreover, Fig. 4.5 shows
that the required voltage for the 90o flip angle is 320 volts using standard STEAM and
is 253 using STEAM with VERSE, i.e. the voltage reduced by 28 % using STEAM
with VERSE pulses. It is important that all the following measurements, either in
vitro or in vivo have been done using STEAM with VERSE pulses.
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Table 4.3: The resultant data at 3T and 7T.
(Cf) Vcal New (Cf)
1.308 352.7 1.003
1.102 306.4 1.000
0.925 421.6 0.968
1.058 421.6 1.031
1.327 349.6 1.085
0.913 387.1 0.989
4.3 Database Spectra Measured at 7T
All in vito spectra in the experimental basis set were acquired with high S/N. Moreover,
single volume spectroscopy (SVS) as localization method, STEAM with VERSE pulses,
and intensive shimming were a good combination to accomplish the acquisition of high
quality spectra.
STEAM with VERSE pulses has been used with short TE = 20 ms and long TE =
74 ms. All the in vitro measurements of 20 metabolite solutions were acquired at 7T
with TR = 3000 ms and (TE = 20 ms and TM = 15 ms) and (TE = 74 ms and TM
= 68 ms) as shown in Figs. 4.6 and 4.7, respectively. The advantage of using short
TE is that the SNR is higher than that of the long TE. However, long TE indicates a
reduction in the baseline distribution.
4.4 Comparison between Measured and Simulated
Glutamate Spectrum
Although the experimental database reflects all the real conditions of the experimental
measurements, the materials used cost money. In this work, the simulated database
spectra have been simulated using the nuclear magnetic resonance simulation program
NMR−SIM . This program attempts to simulate the real scan parameters, although
the calculation is based on an ideal spectrometer and ignores the effect of magnetic
field inhomogeneity. NMR−SIM (learning version) is based on a density matrix with
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Figure 4.5: Comparison between the STEAM and STEAM with VERSE pulses.
relaxation phenomena implemented using a simple model based on Bloch equations.
[67]. The spin system of 20 human brain metabolites and the pulse sequence are
explained in the previous chapter and illustrated in detail in Appendix (C). Fig. 4.8
shows a simulated (red line) and measured (blue line) spectra of glutamate with 20
ms at 7T. This figure indicates the peaks of the CH2 group at 2.35 ppm of the two
databases. Therefore we can use the simulated database to create the LCModel basis
set to analyze the human data.
4.5 Comparison between Experimental and
Simulated Basis Sets
Figures 4.9 and 4.10 show the fit of the 1H-MRS human brain spectrum measured in
the Brodmann 23C region from a healthy volunteer using experimental and simulated
basis sets, respectively. The LCModel fit is the same in both figures. Further, the
SNR are the same and also the two baselines are identical. However, the absolute
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Figure 4.6: Twenty metabolite spectra of the in vitro database using TR = 3 s, TE =
20 ms and TM = 15 ms at 7T
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Figure 4.7: The 20 In vitro spectra of metabolite solutions using long TE = 74 ms and
TM = 68 ms at 7T
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Figure 4.8: Simulated and experimental spectra of Glutamate solution using TE = 20
ms at 7T
concentration of the human brain metabolites in both Figs. are not well matched
as the fact that in the simulation processing the real conditions are neglected. The
simulation runs in the ideal condition of ideal spectrometric devices. Even though
there are some differences between the concentration values in two LCModel fits, these
values closely approached to values of the previous study [47].
Table 4.4 illustrated the comparison between the absolute concentration of 6 healthy
subjects; (mean ± SD) of human brain metabolites using experimental and simulated
basis sets. The differences in the two quantifications are because the experimental data
were acquired under real conditions; therefore, different parameters did not match with
the simulation process, such as the temperature, receiving / transmitting coils and the
signal noise.
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Figure 4.9: LCMdel fit of 1H-MRS human brain spectrum measured in the Brodmann
23C region from a healthy volunteer using experimental basis set with TR = 3 s, TE
= 20 ms and TM = 15 ms at 7T
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Figure 4.10: 1H-MRS human brain spectrum measured in the Brodmann 23C area
from a healthy volunteer. The red line shows the LCModel fit using the simulated basis
set (WIN-SIM) with TR = 3 s, TE = 20 ms and TM = 15 ms and at 297.14 MHz (7T)
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Table 4.4: Comparison between the absolute concentrations of the human brain
metabolites of 6 healthy subjects at 7T using simulated and experimental basis sets
Metabolite Experimental basis set Simulation basis set
Concentrations ± SD Concentrations ± SD
NAA 9.31 ± 1.90 9.43 ± 2.02
Cr 5.82 ± 1.16 5.21 ± 0.90
Glu 8.62 ± 0.85 9.58 ± 1.03
Gln 2.09 ± 0.97 1.32 ± 1.22
GABA 0.85 ± 0.21 0.94 ± 0.27
4.6 Human Acquisition Time Optimization
In the earlier studies [15], STEAM has been used under completely relaxed conditions
TR = 6000 ms and TE = 20 ms in order to minimize corrections due to T1 and T2
attenuation , and the spectra of metabolites with strongly coupled resonances can be
depicted. Moreover, errors due to the different T1 times of protons within a metabolite
are avoided by using fully relaxed in vivo spectra with TR = 6 s at 2T [68].
As a follow up of these studies, the proton MR spectra were obtained using the
STEAM with VERSE pulses with TR = 2, 2.5, 3 s and TE = 20 ms has been used to
optimize the TR and number of averages, where the signal to noise ratio is a function of
TR and the number of average (Av) together. Fig. 4.11 shows three spectra acquired
from a human brain. The acquisition time (At) is selected to be constant and equals
6 mins and 40 seconds. Table 4.5 represents three groups of data measured in the
pgACC brain region and acquired at 7T. The results of these in vivo measurements is
that TR = 3 s and Av = 128 are the optimized parameters in this study.
4.7 Analysis of Human Brain Data using Short and
Long TE Database
Fig. 4.12 and Fig. 4.13 show the 1H-MRS human brain spectra measured in the
pgACC region with the short echo time TE = 20 ms and the long TE = 74 ms,
respectively. The in vivo data was analyzed using LCModel of the basis sets using
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Figure 4.11: Three human brain spectra measured in the pgACC region with different
number of averages and TR of the same healthy subjects. (A) TR = 3000 ms, averages
= 128 (B) TR = 2500 ms, averages = 152 (C) TR = 2000 ms, averages = 192.
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Table 4.5: Three groups of spectra measured in the pgACC brain region of five healthy
subjects at 7T.
Group TR (s) Averages At (min) S/N
A 3 128 6.4 310.52 ± 43.82
B 2.5 152 6.4 283.85 ± 44.54
C 2 192 6.4 263.72 ± 42.13
short and long TE. The SNR and full width at half maximum (FWHM) of NAA
metabolite using short TE are FWHM = 0.032 ppm and S/N = 28. However, with
long TE = 74 ms are FWHM = 0.032 ppm and S/N = 22. This result conforms the
previous observations of the phantom measurements. Also, the LCModel fit at TE =
74 ms illustrates the signal decay of the macromolecules (MM) and lipids, especially
in the range from 0.2 ppm to 2 ppm.
4.8 Comparison between the 3T and 7T Human
Spectra
4.8.1 Using PRESS at 3T and STEAM with VERSE Pulses
at 7T
All measurements were done using healthy volunteers. The volume of interest (VOI)
was selected according to the anatomical dimensions of the pgACC target regions. Fig.
4.14 (A and B) shows the human brain spectra measured in the pgACC region with
128 averages at 7T using STEAM with VERSE (TR/TE/TM = 3000/20/15 ms, Vf =
1.4) and at 3T [69] PRESS with TR/TE = 2000/35 ms and 256 of averages were used
.
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Figure 4.12: LCModel fit spectrum of the human brain data measured in the pgACC
region using the simulated basis set of TR=3000 ms, TE = 20 ms and TM = 15 ms at
7T
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Figure 4.13: LCModel fit spectrum of human brain data measured in the pgACC region
using the simulated basis set of TR=3000 ms, TE = 74 ms and TM = 68 ms at 7T
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4.8.2 Using STEAM with VERSE Pulses at 7T and JPRESS
at 3T
A comparison was done between the quantitative metabolite concentrations of
glutamine, glutamate, N-acetylaspartate, gamma-aminobutyric at 3T [70] and their
concentrations at 7T (in this study). The spectra were measured in the pgACC region.
Table 4.6 shows the metabolite concentrations that are given relative to creatine as
published in the corresponding study [70]. The results of our measurements at 7T
concur well with this study that used J-resolved PRESS (JPRESS) spectroscopy with
rather long scan times of 16 mins and a large voxel size of approximately 17 mL
compared with 1.75 mL in our 7T data. A further advantage is that, although JPRESS
provides encoding of the J-coupling, thus improving the specificity in detecting the
J-coupled metabolites and alleviating the major limitation of 1D MRS [71], using the
STEAM adapted with VERSE at 7T has proved sufficient to detect J-coupled human
brain metabolites such as Gln, Glu and GABA in a shorter scan time relative to the
corresponding study.
Table 4.6: Comparison between the relative concentration levels of metabolites in
pgACC at 7T using STEAM with VERSE at 7T and PRESS at 3T (3 subjects) relative
to JPRESS at 3T.
STEAM with VERSE PRESS JPRESS
at 7T at 3T at 3T [70]
Metabolites Mean ± SD Mean ± SD Mean ± SD
Cr (mM/kg) 5.45 ± 0.85 7.51 ± 0.77 6.30 ± 0.96
GABA/Cr 0.25 ± 0.07 0.18 ± 0.13 0.21 ± 0.07
Gln/Cr 0.29 ± 0.12 0.25 ± 0.43 0.34 ± 0.15
Glu/Cr 1.42 ± 0.26 1.03 ± 0.63 1.35 ± 0.13
NAA/Cr 1.56 ± 0.17 1.53 ± 0.35 1.50 ± 0.15
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Figure 4.14: Human brain NMR spectra were acquired from the pgACC region in
one volunteer a) at 7T using STEAM with VERSE, 128 averages, TR/TE/TM =
3000/20/15 ms, and voxel volume = 1.8 mL and b) at 3T using PRESS, 256 averages,
TR/TE = 2000/35 ms, voxel volume = 2.5 mL, together with the LCModel fitting
curve.
4.9 Human Brain Spectra Measured in Five
Different Locations
Study of the human brain metabolism non-invasively can be done using 1H-MRS
method which can be used markers for specific diseases [1, 2]. Clinical magnetic
resonance spectroscopy MRS has attracted much attention in recent years [72]. As
the proton is the most sensitive stable nucleus, and as almost all the metabolites
contain hydrogen atoms, this study focused on the proton excitation method 1H-MRS.
STEAM with VERSE pulses was used to perform a noninvasive chemical analysis on
tissues the deep within the human brain of the subjects. Moreover, short echo time
and reproducible water suppression increased the number of metabolites which can
be detected and identified [73].Roland Kreis in 1991 [74] used the Localized 1H MR
spectroscopy technique with short echo TE = 30 ms to acquire human brain spectra
from an area in the parietal cortex of three patients suffering from chronic hepatic
encephalopathy and compared them with the equivalent spectra obtained from healthy
control subjects at 1.5T. Also, in 2011 MRS was used in clinical diabetes, a disease
where the increase in Intramyocellular acetylcarnitine associated with moderate aerobic
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exercise in individuals with type 1 diabetes was significantly higher in euglycemia than
in hyperglycemia. Moreover, Boss and Kreis at 1.5T [72] have used the localized
volume of 2.4 mL, PRESS spectroscopy localization with TR of 3 s, TE of 20 ms.
Spectra were analyzed using time and frequency domains (TDFDFit) [75]. In this
work, a linear combination model (LCModel) has been used to analyze the in vivo
data. The LCModel is working in the frequency domain, where the metabolite peak
area is used in absolute concentration calculations.
4.9.1 Parietal Region
Fig. 4.15 shows analyses of a phase-corrected spectrum measured at 7T in the parietal
brain region using the single volume spectroscopy technique. Fig. 4.15 (A) indicates
the volume of interest in the reference image. The thin line indicates the raw data
while the solid line shows the LCModel fit (red color) as seen in Fig. 4.15 (B and C),
respectively. The narrow line width FWHM = 0.027 ppm of NAA indicates a good
field homogeneity at 7T. Besides, the human brain metabolites (Glu and Gln), (Cr and
PCr) and (NAA and NAAG) can be separated and detected at 7T, which normally
does not separate at a lower magnetic field strength [15, 76].
Table 4.7 shows the absolute concentration values of 15 human brain metabolite
measured in a white matter (WM) parietal region of 8 healthy volunteers age 25 -
45 years. In addition to the CRLB values of the quantification. The concentrations
and CRLB values have been obtain from LCModel analyses. All the metabolites show
CRLB values less than 20 % except for Gln, which has a value of 22.25 ± 1.92. This
CRLB value of Gln is acceptable in the WM regions. Moreover, in this region NAAG
can be resolved from NAA at 7T and also in various other brain regions as will be
discussed further on.
4.9.2 Pregenual Anterior Cingulate Cortex (pgACC)
Functional imaging studies suggest a specific role of the anterior brain regions in the
pathogenesis of major depression. Auer et al. in 1999 [77] evaluated the possible
neurochemical alterations in the frontomesial cortex in patients with a major depressive
episode using 1H-MRS with PRESS of TR/TE = 2000/35 at 1.5 T. Further, Glu
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Figure 4.15: In vivo 1H −NMR spectrum acquired from the parietal white matter at
7T. STEAM with VERSE (Vf = 1.4), TR/TE/TM = 3000/20/15 ms, voxel volume =
151515 mm3, BW = 3600 Hz, acquisition size = 2048, and averages = 128. (A) VOI
location (B) measured data (C) LCModel fit of the spectrum
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Table 4.7: Concentration levels of human brain metabolites of 8 healthy volunteers in
the parietal region.
VOI = 3.38 mL (parietal region (WM))
Metabolites Concentrations CRLB ± SD
Mean ±SD (mM/kg) (%)
Asp 2.42 ± 0.25 17.00 ± 4.42
Cr 4.67 ± 0.93 2.25 ± 0.43
GABA 1.23 ± 0.24 17.50 ± 6.02
Gln 1.17 ± 0.31 22.25 ± 1.92
Glu 6.45 ± 1.19 5.50 ± 1.12
GPC 1.31 ± 0.29 7.25 ± 1.48
GSH 1.38 ± 0.19 12 ± 3
Ins 2.58 ± 0.36 7.25 ± 1.48
NAA 10.82 ± 1.54 2.00 ± 0.00
NAAG 0.90 ± 0.27 7.75 ± 1.30
PCr 2.91 ± 0.64 9 ± 2
PE 2.46 ± 0.89 13 ± 6
Tau 1.2 ± 0.35 19 ± 8
GPC + Cho 2.75 ± 0.43 3.1 ± 0.04
Ins + Gly 3.28 ± 0.31 6.75 ± 1.64
and Gln peaks cannot be successfully resolved using PRESS at 1.5 T because of
the overlapping of the metabolite peaks of Glu, Gln and GABA [23, 24]. Moreover,
Glu and Gln were often indistinguishable at lower field strengths [78]. Also, the Glx
(Glu and Gln) signal is primarily dominated by Glu [79, 80]. As the majority of the
available studies suggests higher Glx levels in bipolar patients in the frontal lobe, the
direction of change in the Glx levels appears to be opposite in bipolar and unipolar
affective disorders [81, 82]. All those studies demonstrate that determining the Glu/Gln
concentration is vitally important for patients who suffering from Major Depressive
Disorder (MDD).
Fig. 4.16 shows the LCModel fit of the human brain spectrum acquired from the
grey matter (GM) pgACC region at 7T. Fifteen human brain metabolites have been
detected and quantified with CRLB values less than 20 %, except for NAAG which has
a CRLB value greater than 20 %. It is not mean that there is no NAAG in pgACC
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region but only means that with the scan parameters TR=3 s, TE=20 ms and TM=15
ms were not the best.
Table 4.8: Concentration levels of the human brain metabolites of 8 healthy volunteers
in the pgACC region.
VOI = 3.5 mL (pgACC region)
Metabolites Concentrations CRLB ± SD
Mean ±SD (mM/kg) (%)
Asp 2.08 ± 0.98 16.67 ± 8.08
Cr 5.44 ± 0.85 2.83 ± 0.37
GABA 1.36 ± 0.06 16.50 ± 3.25
Gln 1.59 ± 0.10 12.08 ± 10.40
Glu 7.74 ± 0.22 5.00 ± 1.15
GPC 1.46 ± 0.16 6.50 ± 2.22
GSH 0.74 ± 0.16 13 ± 3
Ins 2.98 ± 0.86 7.00 ± 2.16
NAA 8.51 ± 0.15 2.83 ± 0.13
NAAG 0.19 ± 0.06 31.73 ± 4.45
PCr 1.79 ± 0.18 5.00 ± 1.80
PE 1.44 ± 0.10 11 ± 1
Tau 1.32 ± 0.32 13 ± 3.26
GPC + Cho 1.72 ± 0.16 2.67 ± 0.47
Ins + Gly 3.95 ± 1.37 6.83 ± 1.57
Table 4.8 illustrates the absolute concentration and the CRLB values plus or minus
the standard deviation. The VOI is selected as the grey matter (GM) in the pgACC
region. All the 15 metabolites have a CRLB value less than 20 %. Gln and Glu can
be detected and quantified in this region at 7T.
Also, Taurine (2-aminoethanesulfonic acid) has two methylene groups with
nonequivalent protons, and at higher magnetic fields, it can be regarded as two triplets
centered at 3.25 and 3.42 ppm [83]. The 3.43 ppm Taurine multiplet is relatively clear
from the overlapping metabolites and is clearly seen in the in vitro 1H spectrum, at
3.27 ppm; the Taurine multiplet disappearing because of the CH myo-inositol multiplet
at 3.28 ppm.
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Figure 4.16: The in vivo 1H-MRS spectrum acquired from the pgACC GM at 7T.
STEAM with VERSE factor = 1.4, TR/TE/TM = 3000/20/15 ms, voxel volume =
3.8 mL, BW = 3600 Hz, vector size = 2048, and averages = 128
Results 62
4.9.2.1 NAAG Detection using Simulated Database with Long TE
It is important to mention that the detection of 15 metabolites including Glu and Gln
in a deep region such as pgACC indicates the ability of using this MRS method as
a routine method, particularly for Gln/Glu separation and moreover GABA and Tau
detection at 7T.
Further, the NAAG concentration in this location with short TE shows higher
CRLB values than 20%, but with long TE = 74 ms it can be detected with CRLB
less than 20%. However, it was observed that NAAG could be undetected in all
human brain spectra measured in the pgACC area using short TE = 20 ms, but the
macromolecule MM20 could be quantified using the same echo time.
There is a negative correlation between the CRLB values of the macromolecule
MM20 and that of NAAG with short TE = 20 ms, as shown in Fig. 4.17 (A). However,
Fig. 4.17 (B) also shows a negative correlation between the CRLB values of NAAG
vs. that of MM20 using the long TE = 74 ms and TM = 64 ms. The (mean ± SD)
of concentrations and CRLB values of nine healthy volunteers are illustrated in Table
4.17.
Table 4.9: NAAG, MM20 levels of human brain metabolites of 6 healthy volunteers
in the pgACC region using the long TE = 74 ms.
Metabolites Concentrations CRLB
Mean ± SD (mM/kg) Mean ± SD (%)
NAA 10.89 ± 2.25 2.78 ± 1.09
NAAG 1.01 ± 0.40 14.44 ± 4.30
MM20 2.75 ± 1.56 41.33 ± 41.45
In brief, as seen in Table 4.9 (A and B), NAAG can be detected and quantified with
CRLB less than 20 % with TE = 74 ms and TM = 68 ms used. Where the MM20
signal full relaxed with long TE.
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Figure 4.17: 1H-MRS spectrum acquired from the pgACC grey matter (GM) of 6
healthy subjects at 7T. STEAM with VERSE factor = 1.4, voxel size = 3.8 mL, BW
= 2800 Hz, vector size = 2048, and averages = 128. A) negative relationship between
CRLB of MM20 vs NAAG using TR/TE/TM = 3000/20/15 ms. B) A relation between
CRLB of NAAG vs MM20 using TR/TE/TM = 3000/74/68 ms
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4.9.3 Posterior Cingulate Cortex (PCC)
Fig. 4.18 shows the human brain spectrum of a healthy subject acquired from the PCC
brain region at 7T.
Table 4.10: Concentration levels of the human brain metabolites of 6 healthy subjects
acquired from the PCC area at 7T
VOI = 3.8 mL (pcc region)
Metabolites Concentrations CRLB ± SD
Mean ±SD (mM/kg) (%)
Asp 1.99 ± 0.66 18 ± 0.06
Cho 0.15 ± 0.09 15± 0.04
Cr 6.55 ± 0.11 2 ±0.00
GABA 1.45 ± 0.21 12 ±0.03
Gln 1.97 ± 0.56 10± 0.02
Glu 9.59 ± 0.20 4 ± 0.01
Gly 0.47 ± 0.25 18 ± 0.03
Ins 1.94 ± 0.23 7 ± 0.02
NAA 12.25 ±0.85 2 ± 0.01
NAAG 0.38 ± 0.16 16 ±0.04
GPC 1.17 ±0.20 6 ± 0.02
GSH 0.83 ± 0.23 14 ±0.04
PCr 2.76 ± 0.34 6 ± 0.03
PE 2.65 ± 0.09 6 ± 0.01
Tau 0.67 ± 0.04 18 ±0.04
MM20 7.27 ± 1.64 24.83 ± 4.17
Table 4.10 gives the information of brain metabolites of 6 healthy subjects. The
importance of this section is that this study involved the positions around the corpus
callosum, which is located between the two brain hemispheres, i.e. deeply in the brain,
therefore a volume coil is needed.
In this location, the CRLB value of the Gln metabolite is reduced by 20 %
compared with that of the pgACC. According to the data in the Table, the metabolite
concentration varied in different locations in the brain. Therefore, in the PCC area,
GABA and Tau metabolites can be detected better than in the pgACC area.
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Figure 4.18: The in vivo 1H NMR spectrum acquired from the PCC grey matter at
7T. STEAM with VERSE factor = 1.4, TR/TE/TM = 3000/20/15 ms, voxel size =
3.8 mL, BW = 2800 Hz, vector size = 2048, and average = 128
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4.9.4 Anterior Middle Cingulate Cortex (AMCC)
In this experiment, another brain area was selected using the STEAM with VERSE
pulses with TR/TE/TM = 3000/20/15 ms, average = 128, spectral B.W = 2800 Hz.
Fig. 4.19 shows the human brain spectrum of a healthy subject which was acquired
from the AMCC brain region at 7T. Table 4.11 demonstrates the 15 metabolites of a
human brain, the data acquired from 6 volunteers in the AMCC region at 7T.
Table 4.11: Concentration levels of the human brain metabolites of 6 healthy subjects
acquired from the AMCC area at 7T
VOI = 3.8 mL (AMCC region)
Metabolites Concentrations CRLB ± SD
Mean ± SD (mM/kg) (%)
Asp 2.51 ± 1.37 13.75 ± 5.87
Cho 0.28 ± 0.36 11.25 ± 12.08
Cr 6.30 ± 0.72 2.85 ± 0.86
GABA 1.61 ± 0.85 12.85 ± 7.73
Gln 1.58 ± 0.87 17.80 ± 8.38
Glu 9.15 ± 1.26 4.90 ± 1.18
Gly 0.45 ± 0.38 19.55 ± 16.01
GPC 1.28 ± 0.46 6.85 ± 3.32
GSH 1.00 ± 0.50 17.60 ± 9.38
Ins 2.43 ± 0.70 9.05 ± 7.79
NAA 9.60 ± 2.01 3.20 ± 1.38
NAAG 0.24 ± 0.21 13.20 ± 2.85
PCr 2.28 ± 0.60 14.15 ± 8.88
PE 2.48 ± 0.76 8.45 ± 2.60
Tau 0.68 ± 0.35 21.10 ± 9.34
MM20 6.58 ± 1.47 18.76 ± 5.55
Table 4.11 also illustrates that GABA can be clearly detected in this AMCC location
with lower CRLB value. Moreover, Tau was not quantified as well as in the PCC and
pgACC regions.
Results 67
Figure 4.19: LCModel fit of 1H-MRS spectrum acquired from the AMCC region at
7T. STEAM with VERSE factor = 1.4, TR/TE/TM = 3000/20/15 ms, voxel size =
3.8 mL, BW = 2800 Hz, vector size = 2048, and average = 128
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4.9.5 Brodmann 23C region (23C)
Fig. 4.20 shows the human brain spectrum of a healthy subject acquired from the
Broadmann 23C region of the brain at 7T, including the reference image of the 23C
location. The small fit residual indicates a good match between the raw data and the
LCModel fit. The GLn/Glu metabolites clearly resolved in this region, as shown in
Fig. 4.20. Further, Table 4.12 shows that all the 15 metabolites can be detected as in
the earlier Tables. Moreover, the CRLB values of all the metabolites were less than 20
%.
Table 4.12: Concentration levels of the human brain metabolites of 6 healthy subjects
acquired from the 23c area at 7T
VOI = 3.8 mL (32c region)
Metabolites Concentrations CRLB ± SD
Mean ±SD (mM/kg) (%)
Asp 2.11 ± 1.17 14.67 ± 8.16
Cho 0.24 ± 0.21 16.67 ± 13.53
Cr 6.26 ± 0.84 3.00 ± 0.89
GABA 1.35 ± 0.42 18.17 ± 9.09
Gln 2.14 ± 0.86 15.17 ± 6.24
Glu 8.96 ± 0.84 5.67 ± 1.03
Gly 0.23 ± 0.40 7.50 ± 12.13
GPC 1.23 ± 0.36 8.83 ± 4.02
GSH 0.86 ± 0.25 18.67 ± 3.67
Ins 2.66 ± 0.32 7.83 ± 1.17
NAA 11.05 ± 1.07 2.83 ± 0.75
NAAG 0.34 ± 0.20 17.67 ± 6.47
PCr 2.72 ± 0.17 9.67 ± 2.16
PE 2.73 ± 0.30 8.83 ± 1.33
Tau 0.81 ± 0.17 14.50 ± 2.43
MM20 6.76 ± 1.54 25.00 ± 4.69
At the end of this section, the detection and quantification of 15 metabolites in
the different brain regions proves that the current 1H-MRS method is reliable to use
at 7T. Moreover, using the 24-channel volume coil leads to the acquisition of the data
from the deep brain regions such as around the corpus callosum area. Some metabolites
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Figure 4.20: The LCModel fit of 1H NMR spectrum acquired from the 23C at 7T.
STEAM with VERSE factor = 1.4, TR/TE/TM = 3000/20/15 ms, voxel size = 3.8
mL, BW = 2800 Hz, vector size = 2048, and average = 128
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such as Gln/Glu, NAAG/NAA and Tau/Ins can be detected and resolved very well
using the current method at 7T.
4.10 Human Brain Metabolites Correlation
Some metabolites such as Gln and Glu, may overlap with other metabolites due to
the low field strengths other than 7T. Other metabolites have the same resonance
peaks such as PCr and Cr have the same resonance peaks at 3.01 ppm and 3.9 ppm.
Therefore, the peak overlapping occurs.
4.10.1 Grey Matter and Glutamine Concentrations
Correlation
Fig. 4.21 indicates a relationship between the amount of grey matter in human brain
tissues and the absolute concentrations of the Gln metabolite in the partial and pgACC
regions. The positive correlation ( r=0.881, p=0.00076 ) shows the high significe of the
probability of the existence of a linear relationship between the GM (partial volume)
contents and the Gln concentration in different brain regions.
Table 4.7 indicates that the CRLB value of Gln is 22.25 ± 1.92 which is greater
than 20 %. The reason for this increase can be interpreted because the voxel volume in
parietal regions contains a high amount of WM and a low amount of GM; therefore, the
Gln concentration is minimal. However, most of the other positions, pgACC, AMCC,
PCC and 23C are contained GM which means that the CRLB of Gln should be less
than 20 %.
4.10.2 Gln and Glu Correlation using Short and Long TE
Fig. 4.22 (A and B) shows the correlation between the Glutamine and Glutamate
metabolites with a short echo time TE = 20 ms and with long echo times TE = 74
ms. The metabolite concentrations have been evaluated by the LCModel as absolute
values. Significantly, a positive correlation was found between the Gln values and Glu
values in the pgACC brain region at 7T using the short and long TE. As seen in Fig.
4.22 the short TE illustrates a higher significance ( r=0.71, p=0.03 ) than long TE (
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Figure 4.21: The statistical correlation between GM and Gln using the LCModel fit
spectrum of human brain data of 10 healthy subjects measured in the parietal and
pgACC brain regions with TR/TE/TM = 3000/20/15 ms at 7T
r=0.67, p=0.05 ), respectively. The two correlations show that the Glu/Gln can be
detected with TE = 20 ms and also with TE = 74 ms.
4.11 Fifteen Human Brain Metabolites Detection
in the Different Brain Areas
In the end, the human brain metabolites of healthy volunteers in five locations can be
detected at 7T and quantified using the LCModel. The parietal, pgACC, AMCC, 23C,
and PCC are the five regions examined. Some of these voxels showed the presence of
more white matter (WM), while others contained more of GM; mixed WM with GM
voxels were measured also.
In this study it is established that 15 metabolites could be detected and quantified
using the current 1H-MRS method. All these metabolites can be quantified using
the LCModel with experimental and simulated basis sets. A CRLB value below
Results 72
0 1 2 3 4 5 6 7 8
0
5
10
15
20
25
  R = 0.71592  p = 0.03007
(A)
Gln (mM/L)
G
lu
 (m
M/
L)
0 2 4 6 8 10
0
2
4
6
8
10
12
14
16
18
20
  R = 0.66646  p = 0.049966
(B)
Gln (mM/L)
G
lu
 (m
M/
L)
Figure 4.22: Human metabolites correlation between Gln and Glu using LCModel fit
spectrum of human brain data measured in pgACC region (A) with short TE = 20 ms
and (B) with long TE = 74 ms at 7T
20% has been accepted as the standard value for metabolite quantification. Absolute
concentrations and CRLBs values are given as mean values ± SDs for 30 healthy
volunteers. To calculate the absolute concentrations, the value of 8 mM/kg was
considered as the mean concentration of total creatine (PCr+Cr).
In this work, the 15 metabolites can be classified into two groups depending on
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their WM and GM locations.
4.11.1 Metabolites Detection in WM and GM using TE = 20
ms
NAA, GABA, GSH, GPC, Glu, Asp, Cr, PCr, PE, Tau, and Ins are metabolites which
can be detected and quantized with CRLB values less than 10 % in all the five locations
(WM and GM) which were measured using short TE = 20 ms, TR = 3 s and TM =
15 ms.
4.11.2 Human Brain Metabolites Detected in GM using Short
and Long TE
In GM structures, Gln and GABA can be reliably detected using short TE. NAAG,
however, needs long TE for quantification in the GM pgACC locations. The (mean and
SD) CRLB values of the Gln of eight healthy volunteers are 22.25 ± 1.92 in the parietal
area. The increase in the CRLB value is because most of the parietal voxel consists of
more of WM. In the middle of this chapter, GM has shown a positive correlation with
Gln i.e., there is little detection of Gln in a region with large quantity of WM, such as
in parietal regions. Therefore, by enlarging the voxel size to include some of GM, the
Gln can be detected. However, the long TE = 74 ms and TM = 68 ms are the best
parameters to detect NAAG in the GM region such as pgACC, which contains more
GM than WM.
Finally, the results provide a powerful non-invasive tool for routine proton magnetic
resonance spectroscopy of the human brain at a high magnetic field of 7T using a
24-channel volume head coil and a combination of RF sequence with the STEAM with
VERSE pulses, automatic 3D shim, water suppression adjustment and single volume
spectroscopy localization technique.
Chapter 5
Discussion
In this chapter, some results of this study will be discussed. The main objectives of
this work are to develop a suitable 1H−MRS method and to use this method at 7T to
detect the human brain metabolites from different deep brain regions such as pgACC,
PCC, AMCC and the Brodmann (23C) area.
5.1 Optimization of 90o Flip Angle
The true 90o flip angle depends on the VOI position in the sample and may lead to a
reduced MRS signal. The local variation of the flip angle in the sample has occurred
due to the inhomogeneity of B1 in the sample.
Within the adjustment in volume, additional steps like water suppression
adjustment are required to optimize the flip angle for the selection sequence. These
procedures are time consuming and increase the scan time for the patient. In this work,
the desired flip angle can be achieved using Equation 4.1. The experimental results
demonstrated that the best transmitter voltage can be calculated based on the local
water suppression adjustment. Therefore, the flip angle for MR spectroscopy can be
optimized without additional scan time and thus the signal received from the VOI in
the sample can be improved.
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5.2 Reduction of the Applied Voltage of 90o Flip
Angle
Determination of the required voltage was done in order to obtain a true 90o flip
angle, and the method was used to make a comparison between STEAM and STEAM
with VERSE pulses. In short, the experimental result shows that the required voltage
decreased by 28 % using STEAM with VERSE pulses.
5.3 SNR Increase at 7T Compared to 3T
Hill et al. in 1968 showed that the signal to noise ratio is affected by different factors,
like magnetization in the VOI, filling factor, sample permeability, Larmor frequency,
and volume of the RF coil. Also, in another method of SNR calculation [65], the SNR
was found to be proportional to B0 in the sample, besides the aforementioned factors.
All these factors make the dependency of SNR on the magnetic field strength a difficult
issue [8].
Theoretically, increasing the static magnetic field B0 leads to increases in the SNR
[65]. For a comparison between the 3T and 7T, the SNR increases by a factor of 2.3
at 7T relative to 3T when all the other experimental parameters are similar.
In this work, a STEAM sequence was used at 7T and a PRESS sequence at 3T.
Even though the STEAM sequence results in a 50 % signal loss compared with PRESS
due to the stimulated echo signal generation, the SNR increases by a factor of 1.94 from
3T to 7T. Further, the MRS data of three volunteers measured at 3T and 7T have been
corrected for the number of average, the voxel volume, and the line width differences. If
the STEAM signal loss is considered this leads to a factor of 3.88, while this is higher
than the expected; therefore, a number of additional factors may contribute to this
gain. The echo time is shorter with the STEAM sequence and the receiving coil may
be significantly more sensitive at 7T due to the higher number of channels. Thus, the
high sensitivity and increased chemical dispersion at 7T make it possible to resolve
even metabolites with very low concentrations, such as Gln, GABA and NAAG.
Moreover, it has been earlier published that SNR depends on the chemical shift
displacement of the VOI [38]. In this work, two molecules (water and NAA) have
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a displacement of 4x = 0.15 cm for a 1 cm slice thickness. Also, the measurement
should avoid any signal acquired from outside the volume of interest. Therefore, the
gradient spoiling of unwanted signals is a tool used to avoid signal contaminations. In
the in vivo human brain 1H-MRS measurements, fat is one of the unwanted signals
in spectroscopy. Therefore, strong spoiling is especially necessary [84]. Another source
of unwanted signal contributions arises from the fact that RF pulses cannot excite a
rectangular slice profile as required. Also, the water signal, which is large, compared
with the metabolites is another source of signal contamination which can be avoided
by the application of water suppression pulses such as CHESS [38]. Indeed, the line
width broadening is caused by the magnetic field inhomogeneity. Added to this, the
line width is the result of the shimming process.
5.4 GABA, Gln and Glu Quantification using
Short TE at 7T
Kreis et al. in 1991 [74] explained that glutamine, myo-Inositol and the choline
metabolites are important markers in medicine. Moreover, Hasler in 2007 [1] showed a
positive correlation between the GABA and Glx pools in two voxels in the prefrontal
regions at 3T.
In this thesis, at a high magnetic field strength of 7T, there is a reliability to detect
each of the GABA, Gln and Glu separately with CRLB values < 20% as illustrated in
the chapter on Results. Therefore, in all the regions Glu can be detected and quantified
using the LCModel. In the parietal WM location Glu and GABA were found to be
clearly detected with CRLB values less than 20%. Also, in the GM locations, Glu, Gln
and GABA can be detected and their concentrations evaluated with CRLB values <
20%. Statistical correlations between Glu and Gln have been evaluated at 7T using
short TE = 20 ms and long TE=74 ms. This demonstrates that Glu and Gln can be
detected and quantified with either short or long TE in all the five examined regions.
However, NAA and NAAG in the GM pgACC can be only quantified using long TE.
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5.5 Comparison between GM pgACC and WM
Parietal Regions
Differentiation of metabolic concentration between grey matter (GM) and white matter
(WM) in a human study using TR=3 s and TE =20 ms revealed that Gln concentration
was 42 % higher in the GM pgACC than in the WM parietal. This has been
demonstrated by the positive correlation between the GM (partial volume) and Gln
absolute concentrations in the Results chapter.
As shown in Tables 4.7 and 4.8, tCr, GABA, Glu, Gln, GPC, Ins and Tau have
higher concentrations in the GM pgACC than in the WM parietal locations. On the
other hand, Asp, GSH, NAA, NAAG, PE and total choline show higher concentrations
in the WM parietal than in the GM pgACC locations.
5.6 Human Brain Metabolites Quantification
The LCModel has been used to analyze human spectra acquired from five brain
locations (pgACC, AMCC, Brodmann 23C region and PCC) in the WM or GM. The
small fit residuals of their spectra certified that the fit matches the raw data well.
Previous studies showed that at low fields some metabolites such as NAAG, Gln,
GABA, and Tau cannot be resolved due to the overlap between them and the other
metabolites such as NAA, Glu, and Ins. Obviously, the detection of 15 human brain
metabolites in the different brain regions either superficial or deep brain locations, gives
the current method reliability to be used in medical applications.
Moreover, metabolites such as glutamine and glutamate can be separated using
the long echo time [85, 86]. As, the RF pulses, the gradients, and the interpulse
timings TR, TE and TM are essential elements of an MRS optimization. In this work,
STEAM with VERSE pulses of 2.5 ms pulse duration and experimental parameters
TR/TE/TM = 3000/20/15 ms were used to detect the same metabolites in the deep
brain regions.
In fact, the Glutamine and Glutamate peaks can be separated in all the five
locations either in the GM or in WM structures at 7T. Further, Glu can be detected in
all the areas examined with CRLB less than 5 % as the mean value while Gln too can
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be detected in all the regions with CRLB values < 20 % except in the parietal areas
with 22.15 %.
However, NAAG could not be detected at lower than 7T [15] unless specialized
techniques and shimming were used [87]. In the current study, standard STEAM
adapted with VERSE pulses was used to detect NAAG besides NAA in four deep
brain regions with CRLB values less than 20 % except in the GM pgACC area where
NAAG was detected with long TE = 74 ms.
Moreover, in this study, Asp can be detected in different deep brain regions. Mekle
et al. in 2009 [14] showed that Asp could be detected at 7T with mean concentration
of (2.9 ± 0.5), which concurs with this study (2.452 0.46).
Furthermore, the mean of the total creatine concentration (creatine, Cr,
phosphocreatine, PCr and other creatine compounds) along the five brain locations
is (8.336 ± 11.35) mM/kg, which is also in agreement with the reports [47, 14].
Finally, the 7 Tesla ultrahigh field strength, 24-channel volume coil, STEAM with
VERSE pulses and automatic 3D shimming are tools that have been used to detect
15 human brain metabolites in different brain regions. Moreover, we have succeeded
in detecting and quantifying Gln, GABA and NAAG human brain metabolites by
using 1H-MRS at 7T, which could not be separated at the lower field strengths using
the standard MRS sequences (STEAM or PRESS). It is tempting to conclude that
separating Gln and Glu may be useful for patients who suffer from Major Depressive
Disorder (MDD).
Chapter 6
Conclusions
Ultrahigh magnetic field (7 Tesla) can provide spectra from the human brain with high
signal to noise ratio. The measured data at 3T and 7T field strengths (STEAM has
been used at 7T and PRESS at 3T) show that SNR increases at 7T by a factor of
1.79 compared with 3T. This gain is larger than theoretically expected and may be
explained by the slightly shorter echo time for the STEAM sequence and the higher
sensitivity of the 24-channel receive only coil.
The transmission voltage for the highest signal intensity can be calculated based on
the local water suppression adjustment. Therefore, the flip angle for MR-spectroscopy
can be optimized without the additional scan time and thus improve the signal received
from the VOI in the sample.
Variable rate selective excitation (VERSE) has been applied to the standard
spectroscopy sequence (STEAM) to reduce the required RF peak power. Therefore,
the required voltage for true 90o flip angle was reduced by 28 % allowing it to reach
this target flip angle in all parts of the brain.
This optimized method has been applied to in vivo 1H − MRS measurements.
Two different parameter sets have been used: (i) TR/TE/TM =3000/20/15 ms and
(ii) TR/TE/TM =3000/74/68 ms.
For quantification of the spectra, 20 human brain metabolite solutions were
prepared and measured at 7T. These experimental basis spectra were processed for
use in the LCModel. Twenty simulated spectra were calculated using the NMR-SIM
software to form a simulated basis set. The concentration of these brain metabolites
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has been determined from the in vivo spectra using both the LCModel basis sets at
7T.
This study shows that, not only Gln, GABA and NAAG can be detected using the
current MRS method with short or long echo times, but also that this 1H − MRS
method can be used to determine 15 human brain metabolites.
The results show that the proposed method can be employed at 7T in the deep brain
structures (pgACC, AMCC, PCC or Brodmann 23 C) and allows the determination
of absolute and relative concentrations of the human brain metabolites with low error
levels.
In the GM structures, Gln and GABA can be reliably detected using short TE.
Moreover, NAAG can be quantified using long TE for detection in the GM areas.
The partial volume of GM was shown to have a positive correlation with the Gln
concentration, permitting the separation of the different Gln concentrations between
the grey and white matter. On the other hand, long TE = 74 ms and TM = 68 ms
are the best parameters to detect NAAG in the GM regions such as pgACC.
The current MRS method has been successful in the detection and quantification of
15 human brain metabolites at 7T. This allows employing MR spectroscopy in patients.
Moreover, separating the Gln and Glu can be useful for scanning patients who suffer
from Major Depressive Disorder (MDD).
Appendix A
Model Spectra Database: The current basis set consists of twenty in vitro spectra;
Act, Ala, Asp, Cit, Cr, GABA, Glc, Gln, Glu, Gly, GPC, GSH, Ins, Lac, NAA, PCh,
PCr, PE, Suc, and Tau of different concentrations. All the measured spectra are
processed by LCModel.
In this work, experimental basis set has been done using STEAM with VERSE
pulses. The pulse duration = 2.5 ms, TR=3 s, TE=20 ms and TM=15 ms have been
used. All the measured data of these 20 human brain model metabolites have been
analyzed using LCModel.
Table A.1 shows the chemical shift and J-coupling values of human brain
metabolites. TMSP is considered as a singlet resonance at 0 ppm and all the chemical
shifts are related to it. Multiplicity shows the number of peaks in the spectrum, and
also refers to the number of neighbors protons. The symbols of multiplicity are s
(singlet), d (doublet), t (triplet), q (quartet) and m, multiplet [88].
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Figure A.1: In vitro spectra of Aspartate metabolite measured at 7T using STEAM
with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms, voxel size
of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency domain and
the chemical structure of the Aspartate have been demonstrated. The chemical shift
range is from 0.4 ppm to 4.4 ppm.
Figure A.2: In vitro spectra of Phosphocholine metabolite measured at 7T using
STEAM with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms,
voxel size of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency
domain and the chemical structure of the Phosphocholine have been demonstrated.
The chemical shift range is from 0.4 ppm to 4.4 ppm.
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Table A.1: Metabolite chemical structure (carbon and nitrogen groups), proton
chemical shift, multiplicity and J-coupling values for human brain metabolites.
Metabolite Group Chemical Shift (ppm) Multiplicity J (Hz)
using TMSP
Aspartate 2CH 3.8867 dd 3.647
3CH2 2.8021 dd 9.107
Creatine N(CH3) 3.0260 s None
2CH2 3.9110 s None
NH s None
γ − AminobutricAcid 2CH2 3.0082 m 5.372
3CH2 1.8888 qu 10.578
4CH2 2.2828 t 7.755
L-Glutamine 2CH 3.7625 t 5.847
3CH2 2.1360 m 6.500
4CH2 2.4350 m 9.165
Glutamate 2CH 3.7444 dd 7.331
3CH2 2.0424 m 4.651
4CH2 2.3354 m 8.406
Glycine 2CH2 3.5450 s None
Glycerophosphocholine 1CH2 dd 5.77
dd 4.53
7CH2 4.312 m 3.10
8CH2 m 5.90
N(CH3)3 s 6.03
Gluthatione 7CH dd 7.09
7CH2 dd 4.71
2CH t 6.34
3CH2 m 6.36
m -15.48
4CH2 m 6.7
m 7.6
myo-Inositol 1CH 3.5177 dd 2.889
2CH 4.0488 t 9.998
3CH 3.5177 dd 3.006
4CH 3.6114 t 9.997
5CH 3.2652 t 9.485
6CH 3.6114 t 9.482
L-Lactate 2CH 4.0908 q 6.933
3CH3 1.3125 d
N-acetylaspartate 2CH3 2.0050 s
2CH 4.3823 dd 3.861
3CH2 2.6759 dd 9.821
2.4866 dd -15.592
NH 7.8155 d 6.400
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Table A.2: Continuous of Table A.1
Metabolite Group Chemical Shift (ppm) Multiplicity J (Hz)
using TMSP
choline N(CH3)3 3.1890 s None
1CH2 4.0500 m 3.140
2CH2 3.5060 m 6.979
Phosphocreatine N(CH3) 3.0280 s None
2CH2 3.9260 s None
NH s None
NH s None
phosphorylethanolamine 1CH2 3.9825 m 3.182
Taurine 1CH2 3.4190 t 6.742
2CH2 3.2473 t 6.464
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Figure A.3: In vitro spectra of Glycerophosphocholine metabolite measured at 7T
using STEAM with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15
ms, voxel size of 3.5 mL and 2048 data points. Real and imaginary spectra in
frequency domain and the chemical structure of the Glycerophosphocholine have
been demonstrated. The chemical shift range is from 0.4 ppm to 4.4 ppm.
Figure A.4: In vitro spectra of Creatine metabolite measured at 7T using STEAM
with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms, voxel size
of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency domain and
the chemical structure of the Creatine have been demonstrated. The chemical shift
range is from 0.4 ppm to 4.4 ppm.
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Figure A.5: In vitro spectra of Phosphocreatine metabolite measured at 7T using
STEAM with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms,
voxel size of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency
domain and the chemical structure of the Phosphocreatine have been demonstrated.
The chemical shift range is from 0.4 ppm to 4.4 ppm.
Figure A.6: In vitro spectra of γ-Aminobutric Acid metabolite measured at 7T using
STEAM with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms,
voxel size of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency
domain and the chemical structure of the γ-Aminobutric have been demonstrated.
The chemical shift range is from 0.4 ppm to 4.4 ppm.
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Figure A.7: In vitro spectra of Glutamine metabolite measured at 7T using STEAM
with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms, voxel size
of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency domain and
the chemical structure of the Glutamine have been demonstrated. The chemical shift
range is from 0.4 ppm to 4.4 ppm.
Figure A.8: In vitro spectra of Glutamate metabolite measured at 7T using STEAM
with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms, voxel size
of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency domain and
the chemical structure of the Glutamate have been demonstrated. The chemical shift
range is from 0.4 ppm to 4.4 ppm.
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Figure A.9: In vitro spectra of Glycine metabolite measured at 7T using STEAM
with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms, voxel size
of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency domain and
the chemical structure of the Glycine have been demonstrated. The chemical shift
range is from 0.4 ppm to 4.4 ppm.
Figure A.10: In vitro spectra of Gluthatione metabolite measured at 7T using
STEAM with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms,
voxel size of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency
domain and the chemical structure of the Gluthatione have been demonstrated. The
chemical shift range is from 0.4 ppm to 4.4 ppm.
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Figure A.11: In vitro spectra of Lactate metabolite measured at 7T using STEAM
with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms, voxel size
of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency domain and
the chemical structure of the Lactate have been demonstrated. The chemical shift
range is from 0.4 ppm to 4.4 ppm.
Figure A.12: In vitro spectra of myo-Insitol metabolite measured at 7T using STEAM
with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms, voxel size
of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency domain and
the chemical structure of the myo-Insitol have been demonstrated. The chemical shift
range is from 0.4 ppm to 4.4 ppm.
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Figure A.13: In vitro spectra of N-acetylasparate metabolite measured at 7T using
STEAM with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms,
voxel size of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency
domain and the chemical structure of the N-acetylasparate have been demonstrated.
The chemical shift range is from 0.4 ppm to 4.4 ppm.
Figure A.14: In vitro spectra of Phosphorylethanolamine metabolite measured
at 7T using STEAM with VERSE pulses, duration pulse of 2.5 ms,
TR/TE/TM=3000/20/15 ms, voxel size of 3.5 mL and 2048 data points. Real
and imaginary spectra in frequency domain and the chemical structure of the
Phosphorylethanolamine have been demonstrated. The chemical shift range is from
0.4 ppm to 4.4 ppm.
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Figure A.15: In vitro spectra of Taurine metabolite measured at 7T using STEAM
with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms, voxel size
of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency domain and
the chemical structure of the Taurine have been demonstrated. The chemical shift
range is from 0.4 ppm to 4.4 ppm.
Appendix B
The following metabolites did not quantified.
Figure B.1: In vitro spectra of Acetate metabolite measured at 7T using STEAM
with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms, voxel size
of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency domain and
the chemical structure of the Acetate have been demonstrated. The chemical shift
range is from 0.4 ppm to 4.4 ppm.
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Figure B.2: In vitro spectra of Alanine metabolite measured at 7T using STEAM
with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms, voxel size
of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency domain and
the chemical structure of the Alanine have been demonstrated. The chemical shift
range is from 0.4 ppm to 4.4 ppm.
Figure B.3: In vitro spectra of Citrate metabolite measured at 7T using STEAM with
VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms, voxel size of
3.5 mL and 2048 data points. Real and imaginary spectra in frequency domain and the
chemical structure of the Citrate have been demonstrated. The chemical shift range
is from 0.4 ppm to 4.4 ppm.
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Figure B.4: In vitro spectra of Glucose metabolite measured at 7T using STEAM
with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms, voxel size
of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency domain and
the chemical structure of the Glucose have been demonstrated. The chemical shift
range is from 0.4 ppm to 4.4 ppm.
Figure B.5: In vitro spectra of Succinate metabolite measured at 7T using STEAM
with VERSE pulses, duration pulse of 2.5 ms, TR/TE/TM=3000/20/15 ms, voxel size
of 3.5 mL and 2048 data points. Real and imaginary spectra in frequency domain and
the chemical structure of the Succinate have been demonstrated. The chemical shift
range is from 0.4 ppm to 4.4 ppm.
Appendix C
The simulated bases set based on two parameters (1) RF pulse sequence and (2) Spin
system of each metabolite. The pulse program can be written using the SIM-WIN
program (teaching version) [67]. Figure C.1 demonstrates the STEAM with VERSE
pulses which used in the simulation process. Figure C.2 shows the simulated spectrum
of the analine (Ala) metabolite using STEAM with VERSE pulses, pulse duration of
2.5 ms, TR/TE/TM =3000/74/68 ms. The pulse program of STEAM with VERSE
pulses can be described as following
; STEAM with VERSE sequence
1 ze
2 d1
p16:sp0
d2
p16:sp0
d3
p16:sp0
d4
go=2
ihc
lo to 2 times l1
wr ]0
exit
Spin System Definition
Each line in the description file of spin system contains at most one command. The
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Figure C.1: STEAM pulses using the NMR simulation program. The sinc pulse
matched with the same pulse used at 7T device i.e., included VERSE pulses.
TR/TE/TM=3000/74/68 ms
lines starting with a semi-colon (;) are comments. Several molecules can be defined in
one spin system description file. The molecules are completely independent, NMR-SIM
calculates the resulting signal as a weighted mixture of signals from single molecules.
The limitation of this method is that it is not possible to define an interaction
between nuclei in different molecules. Every molecule must have a command line that
is ( molecule, molecule-name and the relative concentration of this molecule in the
mixture) for example of alanine molecule (molecule alanine 1). The syntax of nuclei
of spin (1/2) can be written as ( nucleus [multiplicity *label] [chemical shift] [relax.
times] ), for example (proton 3*b 1.46 t1=3 t2=0.27 ) respectively. Moreover, the
command (couple a b j) represents the j-coupling between two nuclei a and b. In the
end the file ended by command (endmol).
;example of a spin system of alanine with TMSP and Na-formate molecules (Ala.ham)
; Metabolite Alanine:
molecule alanine 1
;CH-Group (c2)
proton a 3.7746 t1=3 t2=0.270
;CH-Group (C3)
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proton 3*b 1.4667 t1=3 t2=0.270
;proton-proton coupling:
couple a b 7.234
;molecule tsps
Proton y 0.00 t1=3 t2=0.270
;molecule formate 1
Proton x 8.44 t1=3 t2=0.270
endmol
Figure C.2: Simulated in vitro spectrum of alanine using NMR-SIM program at
7T. The simulated spectrum includes two singlets reference peaks TMSP and
Na-Formate at 0 and 8.4 ppm, respectively. Also the peak of water is included
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